Stockwinners Market Radar for October 09, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
SIX | Hot Stocks18:52 EDT Six Flags granted lease agreement to manage Magic Waters Waterpark in Illinois - The Rockford Park District Board of Commissioners has approved a lease agreement that allows Six Flags Entertainment Corporation to operate Magic Waters Waterpark starting in the spring of 2019. This lease agreement is expected to be signed in the near future, and allows the largest regional theme park company in the world to bring its unique and innovative brand to the Rockford market. Magic Waters Waterpark, a 43-acre waterpark located in Rockford, Illinois, has been owned and operated by the Rockford Park District since 1988. The lease agreement is expected to be finalized in the near future and commence in spring of 2019.
|
DUK | Hot Stocks18:51 EDT Duke Energy estimates up to 200K power outages in FL from Hurricane Michael - Based on Hurricane Michael's current forecasted track, Duke Energy Florida projects 100,000 to 200,000 power outages in the northern part of its service area on the Florida Panhandle. The outage projections are based on the company's storm modeling tool, which analyzes variables including storm magnitude, wind speed, size of the wind field and ground saturation. Duke Energy anticipates significant, widespread power outages, particularly along the coastline of the company's service area due to storm surge.
|
IDT... | Hot Stocks18:45 EDT Fly Intel: After Hours Movers - HIGHER AFTER EARNINGS: IDT Corp (IDT) up 27.8%. ALSO HIGHER: NIO (NIO) up another 6.9% after Tesla investor disclosed 11% stake... PPG Industries (PPG) up 4.9% after Trian disclosed 2.6M stake in 13F-HR/A filing... International Paper (IP) up 2.3% after announcing $2B stock buyback and raising dividend... Avrobio (AVRO) up 1.8% after being initiated with a Buy at Guggenheim... Sangamo Therapeutics (SGMO) up 1.3% after being initiated with a Buy at Guggenheim... MongoDB (MDB) up 0.6% after acquiring mLab... Campbell Soup (CPB) up 0.5% after Third Point raised its stake. LOWER: Trinseo (TSE) down 7.7% after cutting Q3 EPS guidance due to higher raw materials... Vipshop (VIPS) down 2.6% after being downgraded to Neutral at JPMorgan... Chubb (CB) down 0.5% after filing mixed shelf.
|
DDAIF | Hot Stocks18:30 EDT Daimler's Mercedes-Benz unveils GLC F-Cell, a 'unique' plug-in hybrid - Daimler's Mercedes-Benz unveiled the GLC F-Cell, a "unique" plug-in hybrid that combines innovative fuel-cell and battery technologies for the first time: apart from electricity, it also runs on pure hydrogen. Intelligent interplay between battery and fuel cell, long range, and short refuelling times make the GLC F-CELL a vehicle of high everyday practicality and also suitable for short and long-distance motoring, the car maker said. With 4.4 kg of hydrogen on board, the SUV generates enough energy for a range of up to 478 km in hybrid mode. The large lithium-ion battery delivers up to 51 km of range in the NEDC. An output of 155 kW guarantees both dynamic performance and locally emission-free driving pleasure. Initial vehicles are to be handed over to selected customers at the end of October. Reference Link
|
XEL | Hot Stocks18:16 EDT Xcel Energy recommends that shareholders reject TRC Capital's mini-tender offer - Xcel Energ reported that it has been notified of an unsolicited "mini-tender offer" by TRC Capital Corporation to purchase up to 2.5M shares of its common stock, representing approximately 0.49% of Xcel Energy's outstanding shares. Xcel Energy recommends stockholders not tender their shares in response to this unsolicited mini-tender offer. The offer price is below the current market price of Xcel Energy's common stock.
|
IGC | Hot Stocks18:14 EDT India Globalization Capital files patent application for treatment of fatigue - India Globalization Capital announced that it has filed a provisional method and composition patent application, or IGC-509, with the U.S. Patent and Trademark Office, or USPTO, for the treatment of fatigue and energy restoration. The filing is for a provisional patent and no assurance can be given as to whether or when a registered patent may be granted by the USPTO in the future. This patent filing made on October 4 is one of a series of steps in the Company's development and commercialization plan to support the creation of a branded, hemp/CBD sugar-free energy drink, which was previously disclosed by the Company on September 25.
|
KOD | Hot Stocks18:02 EDT Kodiak Sciences director Robert Profusek buys 10K shares of company stock - Kodiak Sciences director Robert Profusek disclosed in a filing that he had purchased 10,000 shares of Kodiak Sciences at an average price of $10 per share on October 9. The total transaction value was $100,000.
|
PPG | Hot Stocks17:42 EDT Trian's stake in PPG now stands around 7M shares, CNBC says - In its 1313F-HR/A filing earlier, Trian had disclosed a 2.59M share stake in PPG.
|
TSE | Hot Stocks17:35 EDT Trinseo down 3.5% afterhours following a cut in its Q3 earnings guidance - In its press release, the company also stated: "Generally higher raw materials costs, a slowdown in the automotive industry and the continuation of a weaker tire market negatively impacted the company's Performance Plastics and Synthetic Rubber segments, leading to lower than expected sales volume and margin compression in each of these segments. In addition, operating results in Latex Binders, Synthetic Rubber, and Performance Plastics for the third quarter were negatively impacted by a reduction in customer demand driven by the continued uncertainty of global trade dynamics as well as from customer destocking in anticipation of lower feedstock prices in the future. Our expectation going forward is that weakness in the automotive and tire markets, as well as the slowdown in China will impact our future results to the extent trade uncertainty persists."
|
LTM | Hot Stocks17:32 EDT Latam Airlines reports September passenger traffic up 2.4% - Latam Airlines Group and its subsidiaries reported preliminary monthly traffic statistics for September 2018 compared to the same period of 2017. System passenger traffic increased 2.4%, while capacity rose by 8.0%. As a result, the company's load factor for the month fell 4.5 percentage points to 81.9%. International passenger traffic accounted for approximately 58% of the month's total passenger traffic.
|
IDT | Hot Stocks17:16 EDT IDT up over 33% after Q4 results and suspended dividend in favor of buybacks
|
CPB | Hot Stocks17:15 EDT Third Point raises stake in Campbell Soup to 6.98% from 5.65%
|
ETTX | Hot Stocks17:10 EDT TPG Group Holdings reports 7.81% stake in Entasis Therapeutics
|
AOS | Hot Stocks17:02 EDT A.O. Smith increases quarterly dividend 22% - A. O. Smith Corporation approved a 22% increase in the company's quarterly cash dividend to 22c per share. This is the second increase in the company's dividend rate in 2018. The dividend increase affects the company's common stock and Class A common stock. The dividend is payable on November 15 to shareholders of record October 31.
|
GIB | Hot Stocks17:01 EDT CGI Group board to recommend PricewaterhouseCoopers as its next auditor - CGI announced that its board will recommend that PricewaterhouseCoopers LLP serve as the company's auditor for the fiscal year ending September 30, 2019. This recommendation follows a comprehensive selection process overseen by the Company's Audit and Risk Management Committee and is subject to shareholder approval at its next Annual Meeting in January 2019.
|
ABX GOLD | Hot Stocks17:01 EDT Barrick Gold files management information circular for Randgold deal - Barrick Gold Corporation (ABX) announced that it has filed its management information circular and related voting materials in connection with a special meeting of shareholders to be held on November 5, 2018. The purpose of the meeting is to approve the issuance of Barrick common shares in connection with the merger of Barrick and Randgold Resources Limited (GOLD), as previously announced on September 24, 2018, as well as to approve the continuance of Barrick to the Province of British Columbia.
|
NVS | Hot Stocks16:58 EDT Phase 2 study of Novartis's crizanlizumab shows reduced sickle cell pain - Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal antibody being investigated for the treatment of sickle cell disease, have been published in the American Journal of Hematology. The analysis showed that more patients treated with crizanlizumab did not experience a vaso-occlusive crisis, or VOCs, vs those treated with placebo - 35.8% vs 16.9% - specifically patients with a history of 2-10 VOCs in the previous year. The analysis found that treatment with crizanlizumab may prevent VOCs, both in patients who had 2-4 and 5-10 disease-related pain events in the year prior to the study, as well as those with HbSS. Of the subgroups evaluated, a considerable number of patients across multiple subgroups treated with crizanlizumab did not experience a VOC compared with those treated with placebo.
|
WES APC | Hot Stocks16:52 EDT Western Gas, Anadarko enter gas gathering deal in Delaware Basin - On October 8, 2018, Delaware Basin Midstream, a wholly owned subsidiary of Western Gas Partners (WES) and Anadarko E&P Onshore, a wholly owned subsidiary of Anadarko Petroleum Corporation (APC), entered into a Gas Gathering Agreement for the provision of gas gathering services to AEP in the Delaware Basin in West Texas. The GGA provides for an acreage dedication from AEP for the life of the contract, and consolidates and replaces three separate agreements between subsidiaries of the Partnership and AEP. The GGA runs through December 31, 2032, and will continue from year to year thereafter unless terminated by either party.
|
PPG | Hot Stocks16:43 EDT PPG rises over 5% afterhours following a filing disclosing a stake by Trian
|
PPG | Hot Stocks16:42 EDT Trian Fund Management discloses 2.59M share stake in PPG - In a regulatory 13F-HR/A filing, Trian Fund management disclosed a 2.59M share holding in PPG as of June 30th.
|
UNVR | Hot Stocks16:35 EDT Univar expands relationship with PMC Biogenix on Mexico distribution - Univar announced that its wholly owned subsidiary, ChemPoint.com, has expanded its relationship with PMC Biogenix to include distribution in Mexico, effective September, 2018. Services ChemPoint will manage include order placement, fulfillment, and technical support in Mexico for PMC's Kemamide, Armoslip, Hystrene, and Industrene, branded products along with the metallic stearate portfolio.
|
IDT | Hot Stocks16:35 EDT IDT Corp discontinues quarterly dividend - IDT has discontinued its quarterly dividend, electing instead to return value to stockholders through share repurchases while investing in its growth business initiatives. "The need for additional capital to invest in our growth initiatives as they scale and the current low valuation of the company prompted IDT's Board of Directors to discontinue our quarterly dividend and execute a stock buyback program. The Board determined, and I agree, that we can more effectively enhance long-term shareholder value by using the cash generated by our core offerings to increase investment in our early stage initiatives while retaining the flexibility to return value to shareholders through stock repurchases when warranted by market conditions, available resources, and our business outlook and results, said CEO Shmuel Jonas.
|
NCTY | Hot Stocks16:34 EDT The9 obtains approval to transfer its listing venue to Nasdaq Capital Market - The9 announced that it has obtained approval from The Nasdaq Stock Market to transfer its listing venue from Nasdaq Global Market to Nasdaq Capital Market. The Company's ADSs will continue to trade under the symbol of "NCTY" on Nasdaq Capital Market.
|
IDT | Hot Stocks16:33 EDT IDT Corp reports Q4 adjusted EBITDA $16.8M vs. $8.6M last year
|
WEC | Hot Stocks16:28 EDT WEC Energy names Kevin Fletcher President - On October 8, Allen L. Leverett submitted notice of his resignation as President of WEC Energy Group to the company's Board of Directors, effective at the close of business on October 10, and of his intention to remain as a member of the Company's Board. Mr. Leverett has been on medical leave from the company since suffering a stroke in October 2017. On October 9, the Board accepted Mr. Leverett's resignation as President and confirmed his continuation of service as a member of the Board.Also, on October 9,, the Board appointed J. Kevin Fletcher as President of WEC Energy, with overall responsibility for the operational and financial performance of WEC Energy's utility subsidiaries in Wisconsin, Illinois, Michigan and Minnesota. In his new position, Mr. Fletcher will report directly to Gale E. Klappa, Chairman and CEO of the Company.
|
APAM | Hot Stocks16:26 EDT Artisan Partners reports AUM $116.6B as of September 30th vs. $117.4B last month - Artisan Partners Asset Management reported that its assets under management as of September 30, 2018 totaled $116.6B. Separate accounts accounted for $58.7B of total firm AUM, while Artisan Funds and Artisan Global Funds accounted for $57.9B.
|
GLOB | Hot Stocks16:26 EDT Globant announces promotion of current CFO, Juan Urthiague to succeed - Globant announced the promotion of Alejandro Scannapieco, the current CFO, to executive VP and GM of Globant's U.S. East Region, reporting directly to the CEO of the company. In parallel, the company announced the addition of Juan Urthiague as its CFO. In order to ensure a smooth transition, Scannapieco will assist Urthiague during the next two quarters. Alejandro Scannapieco has been Globant's CFO since 2008 and has successfully led major strategic projects, including the company's IPO in July 2014. Now, as GM of the East Region, Alejandro will be responsible for Globant's business operations and strategic growth in a very relevant region, with the goal of achieving greater presence and recognition. Juan Urthiague has previously worked for Globant, from 2011 until 2017, serving under Scannapieco as global treasurer, investor relations officer, head of financial services and head of corporate finance. He is returning to the company from OLX Group, where he was CFO of the Latam division and was responsible for six companies in twelve countries.
|
AB | Hot Stocks16:22 EDT AllianceBernstein reports preliminary AUM $550B as of September 30th - AllianceBernstein announced that preliminary assets under management decreased to $550B during September 2018 from $551B at the end of August. The 0.2% decline was due to market depreciation, partially offset by total firmwide net inflows. By channel, net inflows to Retail and Private Wealth exceeded net outflows from Institutions.
|
OBSV | Hot Stocks16:20 EDT ObsEva presents clinical data from Phase 3 trial of Nolasiban - ObsEva announced that IMPLANT 2 Phase 3 clinical data of its novel, oral, oxytocin receptor antagonist, nolasiban, in patients undergoing IVF were presented at the 74th annual meeting of the American Society of Reproductive Medicine, taking place in Denver, Colorado, October 6-10, 2018. In the oral presentation entitled "A Placebo-controlled, Randomized, Double Blind, Phase 3 Study Assessing Ongoing Pregnancy Rates After Single Oral Administration of a Novel Oxytocin Receptor Antagonist, Nolasiban, Prior to Single Embryo Transfer" the primary endpoint results of the IMPLANT 2 trial showed an improvement in the rate of ongoing pregnancy 10 weeks post either Day 3 or Day 5 ET, with nolasiban treatment vs. placebo, 35.6% vs. 28.5%, a 25% increase. For women undergoing Day 5 ET, nolasiban resulted in an ongoing pregnancy rate of 45.9% vs. 34.7% for placebo, a 32% increase. Importantly, the tolerability and safety profile of nolasiban has been observed to be comparable to placebo, with no increase in serious adverse events, in ectopic pregnancy, nor in congenital birth defects. In addition, a secondary endpoint of miscarriage rate from weeks 2 to 24 of gestation showed a favourable impact from nolasiban treatment suggesting a reduced miscarriage rate following nolasiban treatment compared to placebo.
|
GHDX | Hot Stocks16:20 EDT Updated NCCN guidelines stresses advantage of Genomic Health's Oncotype DX test - Genomic Health announced that its Oncotype DX Breast Recurrence Score test has been categorized as the only "preferred" test for chemotherapy treatment decision-making for patients with node-negative early-stage breast cancer by the National Comprehensive Cancer Network,NCCN, in its 2018 guidelines for invasive breast cancer chemotherapy treatment. The only test elevated to "strongly consider" guideline inclusion with level 1 evidence, Oncotype DX continues to be distinguished as the only genomic test predictive of chemotherapy benefit. NCCN's guidelines update follows the recent publication of results of Trial Assigning IndividuaLized Options for Treatment , or TAILORx, led by ECOG-ACRIN Research Group. The largest adjuvant treatment breast cancer trial to date, TAILORx involved 10,273 women across 1,100 trial sites in six participating countries. The study results, published in The New England Journal of Medicine, demonstrated that the Oncotype DX Breast Recurrence Score test definitively identifies the vast majority of women with early-stage breast cancer who receive no benefit from chemotherapy, and the important minority of women for whom chemotherapy benefit can be life-saving. Additionally, the NCCN guidelines elevated Oncotype DX into the algorithm for chemotherapy treatment of patients with micrometastases and one to three positive lymph nodes.
|
BKH | Hot Stocks16:19 EDT Black Hills says will deliver tax reform benefits to Arkansas utility customers - Black Hills Corp. announced that its Arkansas gas utility subsidiary, Black Hills Energy, will provide federal income tax reform benefits, resulting from the December 2017 passage of the federal Tax Cuts and Jobs Act, to its customers in Arkansas commencing Oct. 15, 2018. The Arkansas Public Service Commission on Sept. 26, 2018, approved Black Hills Energy's request to pass along the benefits to customers of a lower corporate federal income tax rate, which was reduced from 35% to 21% beginning Jan. 1, 2018. The commission approved the company's request to refund $8.2M of tax reform benefits accumulated from Jan. 1 through Oct. 15, 2018, to utility customers through a monthly credit to their bills beginning in mid-October and continuing through May 2019. For periods after October 15, 2018, the benefits of the reduced federal income tax rate will be included in customer rates. Those benefits will total approximately $1.5M for the period October 15 to December 31, 2018 and approximately $6.2M per year thereafter.
|
IP | Hot Stocks16:18 EDT International Paper increases quarterly dividend 5.3% - International Paper's board raised the quarterly common stock dividend by 2.5c per share, or 5.3%, which brings the per share dividend to 50c per quarter, or $2.00 annually. This dividend is payable on December 14 to holders of record at the close of business on November 15.
|
BKH | Hot Stocks16:17 EDT Black Hills receives approval of rate increase request in Arkansas - Black Hills Corp. announced that its Arkansas gas utility, Black Hills Energy, received approval for a general rate increase from the Arkansas Public Service Commission to recover investments in safety, reliability and system integrity for natural gas service for more than 169,000 customers in Arkansas. The new rates will generate an estimated $12M per year of new revenue. The commission's approval also allows the company to include $10.6M of revenue that is currently being collected through certain rider mechanisms in the new base rates. The new revenue increase is based on a return on equity of 9.61% and a capital structure of 49% equity and 51% debt. Black Hills Energy originally requested $30M in new annual revenues to recover its investment in utility infrastructure and increased operating expenses, driven primarily by the strong growth in northwest Arkansas. The request also included revenue for additional planned staff increases to assist in serving a rapidly growing customer base. Primarily as a result of the reduction in the corporate federal income tax rate due to passage of the Tax Cuts and Jobs Act, the company reduced the request to $18.6M, based on a return on equity of 10.2% and a capital structure of 50% equity and 50% debt. The new rates for customers will take effect Oct. 15, 2018, and will include benefits related to federal income tax reform.
|
IVZ | Hot Stocks16:17 EDT Invesco reports preliminary AUM $980.9B as of September 30th - Invesco reported preliminary month-end assets under management of $980.9B, a decrease of 0.7%. The decrease was driven by unfavorable market returns, net long-term outflows, lower money market AUM and foreign exchange; partially offset by reinvested distributions and non-management fee earning AUM inflows. FX decreased AUM by $0.3B. Preliminary average total AUM for the quarter through September 30 were $985.1B, and preliminary average active AUM for the quarter through September 30 were $736.3B.
|
IP | Hot Stocks16:16 EDT International Paper announces $2B share repurchase program - International Paper announced its board has authorized a share repurchase program to acquire up to $2.0B of the company's common stock. The new authorization is in addition to $430M remaining as of the end of Q3 from a previous repurchase program. The company intends to continue repurchasing such shares in open market transactions.
|
SIRI | Hot Stocks16:15 EDT SiriusXM raises quarterly dividend 10% to 1.21c per share - SiriusXM announced that its board of directors declared a quarterly cash dividend of 1.21c per share of common stock, reflecting an increase of 10% over the previous quarter's dividend. This regular quarterly dividend is payable in cash on November 30, 2018 to stockholders of record at the close of business on November 9, 2018.
|
WEC SO | Hot Stocks16:13 EDT WEC Energy President Allen Leverett to resign, Kevin Fletcher to succeed - WEC Energy (WEC) announced that Allen Leverett, who has been on medical leave since suffering a stroke last October, has decided to resign his position as President of the company, but will continue to serve as a member of the board of directors. The board of directors of WEC Energy announced that it has elected Kevin Fletcher as President of the company. The appointment is effective immediately. Prior to joining the company in November 2011, Fletcher was vice president - community and economic development at Georgia Power, Southern Co.'s (SO) largest subsidiary.
|
VIVO | Hot Stocks16:09 EDT Meridian Bioscience, DiaSorin announce collaboration to sell stool antigen test - DiaSorin and Meridian Bioscience announced that DiaSorin Inc., a subsidiary of DiaSorin and Meridian Bioscience, Inc. have entered into a strategic collaboration to sell DiaSorin's FDA-cleared Helicobacter pylori stool antigen test to detect H. pylori for use on its automated Liason platform under the Meridian brand name worldwide. As part of this agreement, Meridian and DiaSorin will begin collaborating on sales and marketing efforts to hospitals and reference laboratories in the U.S. Moreover, Meridian will receive royalties on sales of the Liason H. pylori stool antigen test in the U.S. and now also in the UK, in addition to the royalties received under the previous agreement. This new collaboration will result in the termination of all pending legal disputes and will expand the scope of the previous agreement between DiaSorin and Meridian, which focused on the sale, by DiaSorin, of co-developed products in major countries in continental Europe.
|
PFMT | Hot Stocks16:09 EDT Performant Financial COO resigns, company has no plans for replacement - Performant Financial announced that Jeff Haughton has resigned as President and COO of Performant to return to the investment banking business. "We want to thank Jeff for his leadership and contributions during the four years he was with us, and we wish Jeff well in his future endeavors," stated Lisa Im, CEO of Performant. "Currently, we have no plans to replace the President or Chief Operating Officer role; rather, we have chosen to reorganize our existing team of strong and dedicated leaders. We believe our revised structure will best align with our business objectives and the functions required to support our goals."
|
MDB | Hot Stocks16:07 EDT MongoDB to acquire mLab - MongoDB announced it has entered into a definitive agreement to acquire mLab, a San Francisco-based cloud database service. The acquisition is expected to close in Q4, subject to the satisfaction of customary closing conditions. MongoDB's acquisition of mLab will help deepen its relationships with developer-centric startup communities, a segment with which mLab has been very successful. mLab currently has approximately 1M hosted databases on its platform across both free and paid tiers.
|
CERS AIMT | Hot Stocks16:06 EDT Cerus appoints Eric Bjerkholt to the board - Cerus Corporation (CERS) announced the appointment of Eric Bjerkholt to its Board of Directors. Mr. Bjerkholt currently serves as the chief financial officer of Aimmune Therapeutics (AIMT), a San Francisco Bay Area biopharmaceutical company focused on the development of treatments to help protect people with food allergies. Mr. Bjerkholt brings over three decades of healthcare and biotech leadership experience to the Cerus Board, which has now been expanded to eight members.
|
SNCR | Hot Stocks16:05 EDT Synchronoss names Jeff Miller chief commercial officer - Synchronoss Technologies announced that Jeff Miller has been appointed to the Synchronoss Leadership Team as its new Chief Commercial Officer, effective October 22. Miller comes to Synchronoss from IDEAL Industries, Inc., where he served as Group President with responsibility for leading the Technology Business Group.
|
ANGI | Hot Stocks16:05 EDT Angi Homeservices appoints Chief Product Officer Brandon Ridenour as next CEO - ANGI Homeservices announced its Board of Directors appointed Brandon Ridenour, Chief Product Officer, as its next CEO to succeed Chris Terrill. Mr. Terrill will remain in the CEO role during a transition period that will be complete by the end of the year, at which time Mr. Terrill will step down as CEO and from the ANGI Homeservices Board of Directors and continue on with the company in an advisor capacity. Following the transition period, Mr. Ridenour will join the ANGI Homeservices Board of Directors along with Craig Smith, ANGI Homeservices' President and Chief Operating Officer. Joey Levin, CEO of IAC and ANGI Homeservices' Chairman said, "Chris led what is now ANGI Homeservices from a little seed within IAC, to a multi-billion-dollar public company at the top of its category, with unbounded potential yet ahead. But perhaps his greatest accomplishment is the depth in the leadership team he built, such that, as he departs, the business can seamlessly continue executing against the massive opportunity remaining in home services. Thank you, Chris."
|
CVLT NTAP | Hot Stocks16:03 EDT Commvault and NetApp expand partnership - Commvault (CVLT) announced that Commvault Complete Backup & Recovery Software is now available for purchase directly from NetApp (NTAP) and NetApp channel partners. Tightly-integrated and a primary backup solution across the NetApp storage portfolio, Commvault Complete Backup & Recovery software provides more features and functionality than previous offerings for any environment, whether it be on-premise, hybrid or in the cloud. The announcement was made in Nashville at Commvault GO 2018, the company's annual customer conference.
|
NIO... | Hot Stocks16:03 EDT NIO jumps after big Tesla investor discloses 11% stake - Shares of NIO Inc. (NIO) rose in Tuesday's trading after Baillie Gifford & Co., which is the largest investor in Tesla (TSLA) after Elon Musk, disclosed earlier that it has taken an 11.4% stake in the Chinese electric vehicle maker. STAKE IN ELECTRIC VEHICLE COMPANY: In a regulatory filing before the open, Baillie Gifford & Co. disclosed that it owns 85.3M NIO Inc. shares. The holding was worth about $515M as of the close of trading Monday and represents a 11.4% stake in the Chinese electric vehicle company. Baillie Gifford & Co. is the second largest investor in Tesla, behind Elon Musk. Tesla's CEO owns 20% of the company, while Baillie Gifford has a 7.7% stake, according to Bloomberg. The latter is not the only major investor that both Tesla and NIO Inc. share. Tencent (TCEHY) also holds 4.9% percent of Tesla and all of a special class of NIO Inc. stock that gives the Chinese tech giant about 22% voting power of issued shares, Bloomberg noted. PRICE ACTION: Shares of NIO Inc., which came public on September 12, jumped about 22% to $7.38 heading into the close of trading on Tuesday.
|
NBIX | Hot Stocks16:02 EDT Neurocrine and Jnana Therapeutics enter into research collaboration - Neurocrine Biosciences and Jnana Therapeutics announced that they have entered into a research collaboration aimed at discovering novel small molecule therapeutics for multiple targets for central nervous system, or CNS, disorders. The collaboration will leverage Jnana's proprietary drug discovery platform across the solute carrier, or SLC, family of transporters and Neurocrine's research and development expertise in CNS disorders to advance new medicines. Under the terms of the agreement, Neurocrine and Jnana will work jointly to identify novel compounds, after which time Neurocrine will be responsible for further lead optimization, and the development and commercialization of any potential therapies arising from the collaboration. Neurocrine will also provide Jnana with one-time access to a subset of its compound library for Jnana to screen for hits on a select number of non-CNS targets. As part of the collaboration, Jnana will receive an up-front payment and committed research funding to support discovery efforts. In addition, Jnana is eligible to receive milestone payments and royalties based upon products resulting from this collaboration.
|
TRCO | Hot Stocks16:02 EDT Tribune Media sells Long Island property for $54.5M - Tribune Media announced that it has closed the sale of a 48-acre parcel of property in Long Island, New York, to Hartz Mountain Industries for $54.5M. The property consists of a 32-acre south parcel that houses the former office and printing operations for Newsday, and a 16-acre north parcel which is available for immediate development.
|
WMLP | Hot Stocks15:57 EDT Westmoreland LP trading resumes
|
PEIX... | Hot Stocks15:47 EDT RFA 'applauds' President Trump's E15 announcement - In a statement published on its website, the Renewable Fuels Association said it "applauds today's announcement by President Donald Trump that the Environmental Protection Agency is beginning a formal rulemaking process to allow year-round sales of E15 nationwide. Currently, E15 - gasoline containing 15% ethanol - cannot be sold during the summer months in most of the country. The de facto summertime ban on E15 is the result of a burdensome, decades-old regulation that offers no environmental or economic benefit whatsoever. Eliminating the summertime barrier to E15 will save consumers money and reduce emissions, enhance competition, and provide a boost to the farm economy." In afternoon trading, shares of Pacific Ethanol (PEIX) have jumped over 9%, while Green Plains (GPRE) and Gevo (GEVO) have dropped about 4%. Reference Link
|
WEX | Hot Stocks15:46 EDT Wex partners with Melbourne-based FinTech Payment Logic - WEX announced a partnership with Melbourne-based FinTech Payment Logic, which will see both companies collaborating to automate the car registration renewal process for businesses in Australia. Payment Logic has developed a Robotic Process Automation solution that, when coupled with WEX virtual payments, enables the automation and payment of the car registration renewal process for fleets of vehicles. This solution takes a file of car registrations and, in an automated fashion, inserts a virtual card payment and enters the registration renewal without any manual input by the fleet owner, manager or administrator.
|
PCG | Hot Stocks15:19 EDT PG&E responds to Cascade wildfire announcement - Pacific Gas and Electric Company issued the following statement in response to the release of information by the California Department of Forestry and Fire Protection, or CAL FIRE, regarding the October 2017 Cascade wildfire: "The safety of our customers, their families and the communities we serve is our most important job. Without question, the loss of life, homes and businesses in these extraordinary wildfires is heartbreaking and we remain focused on helping communities recover and rebuild. As independent experts have confirmed, extreme weather, years of drought, and millions of dead trees are feeding an unprecedented risk of wildfires. In light of this, we recognize we all need to do even more to help reduce the risk of wildfires, and are committed to working together with our state and community partners to develop comprehensive safety solutions for the future. We look forward to the opportunity to carefully review the CAL FIRE report to understand the agency's perspectives. In the meantime, we are continuing to focus on implementing additional precautionary measures intended to further reduce wildfire threats, such as working to remove and reduce dangerous vegetation, improving weather forecasting, upgrading emergency response warnings, making lines and poles stronger in high fire threat areas and taking other actions to make our system, and our customers and communities, even safer in the face of a growing wildfire threat."
|
ERI | Hot Stocks15:18 EDT JCM Global signs exclusive master supply agreement with Eldorado Resorts - JCM Global has signed an exclusive master supply agreement with Eldorado Resorts helping the company to deepen and expand its connection with its players. Under the agreement, JCM will provide its bill validators and printers for all 26 Eldorado gaming properties in the U.S. The agreement is an expansion of existing relationships between JCM and certain Eldorado properties and a conversion for other properties. JCM will provide its iVIZION and UBA bill validators and its GEN5 and GEN2U printers. Eldorado has also been using JCM's award-wining ICB Intelligent Cash Box system at many of its properties.
|
CMI | Hot Stocks15:01 EDT Cummins authorizes $2B share repurchase program - On October 9, The Board of Directors of Cummins authorized the company to repurchase up to $2B in shares of common stock upon completion of its 2016 $1B share repurchase program. The Board of Directors also declared a quarterly cash dividend on common stock at 1.14 dollars per share, payable on December 3, 2018 to shareholders of record on November 15, 2018.
|
CELG | Hot Stocks14:38 EDT Celgene terminates study of CC-90002 in Acute Myeloid Leukemia - A ClinicalTrials.gov post updated yesterday, October 8, shows that terminated a study of CC-90002 in subjects with Acute Myeloid Leukemia, or AML, and high-risk Myelodysplastic Syndrome, or MDS, because "preliminary monotherapy data in relapsed/refractory AML and high-risk MDS did not offer a sufficiently encouraging profile for further dose escalation/expansion." Reference Link
|
AWI | Hot Stocks14:31 EDT Lazard Asset Management reports 10.29% passive stake in Armstrong World
|
PCG | Hot Stocks14:25 EDT PG&E moves off session highs after Cal Fire issues report on Cascade fire - Shares of PG&E are up 54c, or 1.1%, at $48.46, off their earlier highs of the session after Cal Fire issued a report, stating that it has determined the Cascade Fire which occurred during the October 2017 Fire Siege was started by sagging power lines coming into contact during heavy winds. The power line in question was owned by the Pacific Gas and Electric Company, the Cal Fire report stated.
|
PCG | Hot Stocks14:23 EDT Cal Fire says Cascade fire started by sagging power lines owned by PG&E - CAL FIRE has issued a report, stating that it has determined the Cascade Fire which occurred during the October 2017 Fire Siege was started by sagging power lines coming into contact during heavy winds. No violations of the Public Resources Code were found by CAL FIRE. The Cascade Fire in Yuba County, started on the evening of October 8 and burned a total of 9,989 acres, destroying 264 structures and resulted in four civilian fatalities and one firefighter injury. A high wind event in conjunction with the power line sag on two conductors caused the lines to come into contact, which created an electrical arc. The electrical arc deposited hot burning or molten material onto the ground in a receptive fuel bed causing the fire. The common term for this situation is called "line slap" and the power line in question was owned by the Pacific Gas and Electric Company. The investigative report has been forwarded to the Yuba County District Attorney. In total, the October 2017 Fire Siege involved more than 170 fires and burned at least 245,000 acres in Northern California. "CAL FIRE investigators continue to investigate the Tubbs Fire and will release the report once it is completed," the report stated. Reference Link
|
NVCN | Hot Stocks14:12 EDT Neovasc reports regained compliance with Nasdaq minimum bid price rule - Neovasc announced that it has received written notification from the Nasdaq hearings panel notifying the company that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, that it is in compliance with all other applicable continued listing requirements and that the panel has determined to continue the listing of the company's common shares on the Nasdaq. Accordingly, Neovasc is in compliance with all applicable Nasdaq listing standards and the panel considers this matter closed, the company said.
|
IDT | Hot Stocks14:10 EDT IDT unit net2phone releases new business communication platform - net2phone announced the release of a powerful new business communication platform. The platform seamlessly integrates voice, text, messaging and web chat services across devices-- evolving how businesses communicate and collaborate."While voice remains the most common form of business communication, employees, customers, partners and suppliers increasingly prefer text, web chat and social media," said Jonah Fink, President of net2phone. "net2phone's new platform brings these diverse communications channels together through a simple and intuitive online dashboard to create a unified, easy-to-use and powerful communications tool." net2phone's new platform also enables team members to be more productive and engaged whether they are in the office or on the road. "With our new platform, team members can manage all of their communications from any device - transferring conversations seamlessly from PCs, to office phones to mobile devices," Fink added. "Our new mobile apps - available for iOS and Android - turn any smart phone into a convenient, multi-channel communications center for people on the go."
|
BDRBF | Hot Stocks13:56 EDT airBaltic Orders up to 60 Bombardier CS300 aircraft - Bombardier Commercial Aircraft and airBaltic announced that the parties have executed a firm purchase agreement for the sale and purchase of 30 CS300 aircraft with options and purchase rights for an additional 30 aircraft of the same type. Based on the list price of the CS300 aircraft, the firm order is valued at approximately US$ 2.9B. This amount would increase to nearly $5.9B should all 15 options and 15 purchase rights be exercised."As the C Series aircraft program continues to gain market acceptance, this significant reorder from our CS300 launch operator is a strong testimony to the aircraft's exceptional in-service performance,"said Fred Cromer, President, Bombardier Commercial Aircraft. "Furthermore, we are proud that the CS300 has helped airBaltic maintain its position as one of the world's most punctual airlines. The C Series aircraft is at the forefront of the small single-aisle market, and airBaltic played a key role in demonstrating its value. In the last 18 months, we have witnessed airBaltic's growing leadership in the market, and we wish the airline further success with its expanded CS300 fleet." With this order, airBaltic becomes the largest European C Series customer and the second largest customer worldwide with 50 aircraft on firm order. The airline's new business plan relies on significant expansion of routes from all three Baltic countries - Latvia, Estonia and Lithuania.
|
SBUX | Hot Stocks13:44 EDT Starbucks says looks forward to maintaining 'productive dialogue' with Ackman - "We view the active, engaged dialogue that we have with shareholders as critical input into our strategic approach and we value constructive feedback on delivering long-term shareholder value," a spokesperson for Starbucks said in a statement to CNBC. "We look forward to maintaining a productive dialogue with Ackman as we do with all of our shareholders."
|
GEL | Hot Stocks13:35 EDT Genesis Alkali to raise prices for S-Carb, feed grade sodium bicarbonate - Genesis Alkali, a business of Genesis Energy, L.P., announced that, effective immediately or as contract terms permit, it will increase off-list prices for S-Carb, purified sodium sesquicarbonate, and feed grade sodium bicarbonate. This price increase is necessary to cover increasing manufacturing costs, ongoing regulatory compliance requirements and necessary reinvestment in our facilities to meet the demand for high quality sodium buffer products. Genesis Alkali said: "As always our first commitment is to safely producing high quality Animal Nutrition products and meeting our customers' needs as a reliable supplier. We are proud to be an active member of the Animal Nutrition Industry with a goal of safely feeding the world."
|
ZNGA | Hot Stocks13:27 EDT Zynga jumps after Bloomberg reports on takeover interest - Shares of mobile game maker Zynga (ZNGA) are rising sharply in afternoon trading after Bloomberg reported that the company has received takeover interest. The maker of Words with Friends has received preliminary approaches, but no formal talks are taking place, Bloomberg added, citing sources. In afternoon trading after the report, Zynga shares have spiked up 23c or 6%, to $4.11.
|
AXP | Hot Stocks13:23 EDT American Express announces Mohammed Badi joining as Chief Strategy Officer - American Express announced that the company is creating a new Executive Committee level position of Chief Strategy Officer. Mohammed Badi, currently Senior Partner, Managing Director and Global Leader of the Payments Practice & Transaction Banking at The Boston Consulting Group, will be joining American Express on October 29 to take on this new role, reporting directly to Chairman and CEO Stephen Squeri. "Given the changing dynamics of the payments landscape, both strategic planning and corporate development activities are becoming increasingly important to our company. For this reason, we are separating these functions into two distinct groups and creating the new CSO position in order to increase our focus on both of these critical, forward-thinking activities," the company added. Reference Link
|
OPNT | Hot Stocks13:15 EDT Stonepine Capital Management reports 5.7% passive stake in Opiant Pharmaceuticals
|
CEIX | Hot Stocks12:51 EDT Azvalor Asset Management reports 12.0531% passive stake in Consol Energy
|
ATVI... | Hot Stocks12:44 EDT Game On: Microsoft unveils Project xCloud a week after Google's Project Stream - Welcome to "Game On," The Fly's weekly recap of the stories powering up or beating down video game stocks. NEW RELEASES: This week's major new release is Activision Blizzard's (ATVI) multiplayer shooter "Call of Duty: Black Ops 4," which rolls out October 12 for PlayStation 4 (SNE), Xbox One (MSFT), and PC. Also out this week is Nintendo's (NTDOY) "Luigi's Mansion," a port of the GameCube launch title from 2001. The game comes out October 12 exclusively for 3DS. PROJECT XCLOUD: Yesterday, Microsoft announced Project xCloud, the software and technology giant's new service that will allow the steaming of Xbox One games across computers, phones, and tablets. The company noted that scaling and building out xCloud is a "multi-year journey" and that it will start public trials in 2019. The news comes a week after Google (GOOG, GOOGL) announced Project Stream, which is intended to give players the ability to stream console-quality video games directly to the Chrome browser. POTENTIAL NEW CONSOLES: According to the Financial Times, Sony CEO Kenichiro Yoshida confirmed that a successor to the PlayStation 4 is going to happen, though he declined to confirm whether or not the next console will be named the PlayStation 5. "At this point, what I can say is it's necessary to have a next-generation hardware," Yoshida told the publication in an interview. The news comes several days after the Wall Street Journal reported that Nintendo is planning to release a new version of its popular Switch console in the latter half of 2019. PIPER SURVEY: Last week, Piper Jaffray analyst Michael Olson sent a research note to investors discussing the "critical" pre-holiday window for game releases. In an effort to gauge interest in the crowded holiday title slate, the firm conduct a second survey of roughly 300 gamers to determine any shifts from Piper's previous batch of results. The latest survey shows that Activision Blizzard's "Call of Duty: Black Ops 4" and Take-Two's (TTWO) "Red Dead Redemption 2" are the most anticipated games for pre-holiday 2018, with the next three being Ubisoft's (UBSFY) "Assassin's Creed Odyssey," Bethesda's "Fallout 76," and Electronic Arts' (EA) "Battlefield V." In addition, the analyst said his analysis of YouTube trailer likes-to-dislikes shows "Red Dead Redemption 2" is, by far, the most "liked" of the upcoming games. Meanwhile, the analysis showed that gamer interest for "Battlefield V" was "weak," as trailers for the game have more dislikes than likes. While the analyst rates each of the major publishers as Overweight, Olson said that, based on most potential for upside through the second half of calendar year 2018, he ranks them relative to each other as follows: Take-Two first, Activision second, and EA third.
|
WMLLF ALB | Hot Stocks12:41 EDT Wealth Minerals names Albemarle's Cesar Jil as CTO for Chile - Wealth Minerals (WMLLF) announced earlier today that it hired Cesar Jil, formerly Manager of Lithium Extraction Technologies at Albemarle (ALB), as Chief Technical Officer for Chile, effective immediately. Henk Van Alphen, Wealth's CEO, said, "Great to have such a high calibre professional join the Wealth team and put the Company ever closer to advancing our projects to production. There are very few people in the world who know how to run a lithium brine operation, and Wealth managed to hire one of the best from this small group. I take great pride in knowing that Cesar left a successful career at a large multinational corporation to join Wealth for our growth potential and corporate culture. We welcome him and are excited about Wealth's next steps." Shares of Albemarle in midday trading are down 3%, or $3.47, to $98.78.
|
GOOG... | Hot Stocks12:12 EDT Google announces Pixel 3, Pixel 3 XL phones - Google's (GOOG, GOOGL) new Pixel phones will come with new YouTube music free for 6 months. The phone boasts a second front-facing camera to capture 148% more of the scene. The Pixel 3 camera comes with Google Lens integrated. Pixel 3 also comes with free unlimited photo storage at original quality. The Pixel 3's Google Assistant AI comes equipped with screen answer, where the AI will answer a call for you and transcribe the interaction on your screen, removing interactions with telemarketers. The Pixel 3 comes with Google's new Titan security chip. The Pixel 3 starts at $799 and will be available October 18 at Verizon (VZ) and unlocked on the Google Store on November 1. Google's new wireless charging dock for the Pixel 3 is priced at $79. The phone is available for pre-order now.
|
GOOG GOOGL | Hot Stocks12:10 EDT Google announces Pixel 3, Pixel 3 XL phones - Google's (GOOG, GOOGL) new Pixel phones will come with new YouTube music free for 6 months. The phone boasts a second front-facing camera to capture 148% more of the scene. The Pixel 3 camera comes with Google Lens integrated. Pixel 3 also comes with free unlimited photo storage at original quality. The Pixel 3's Google Assistant AI comes equipped with screen answer, where the AI will answer a call for you and transcribe the interaction on your screen, removing interactions with telemarketers. The Pixel 3 comes with Google's new Titan security chip. The Pixel 3 starts at $799 and will be available October 18 at Verizon (VZ) and unlocked on the Google Store on November 1. Google's new wireless charging dock for the Pixel 3 is priced at $79. The phone is available for pre-order now.
|
SSC | Hot Stocks12:09 EDT Ideanomics signs JV to create commodity, energy digital asset exchange - Ideanomics, formerly Seven Stars Cloud Group, announced that it has entered into a joint venture agreement with TPJ Ltd, to create Ideanomics Resources LTD a U.K. company based in London. The company says, "The 75% Ideanomics owned joint venture has been created to unlock value in the commodities and energy sectors by leveraging and utilizing the Ideanomics Platform-as-a-Service solutions, a suite of strong multi-layer fintech technologies leveraging blockchain and artificial intelligence. Ideanomics Resources will initially focus its efforts in Africa and Middle East where it has significant long-term relationships." The joint venture will be responsible for setting up a commodity and energy digital asset exchange, which will leverage Ideanomics Platform-as-a-Service solutions.
|
ACN | Hot Stocks12:07 EDT TopLine selects Accenture's Mortgage Cadence - TopLine Federal Credit Union selected Mortgage Cadence, an Accenture company, to modernize its mortgage operations using Mortgage Cadence's full product suite. TopLine has replaced all legacy systems with Mortgage Cadence's Loan Fulfillment Center, Borrower Center, Document Center, Imaging Center and Collaboration Center, paving the way for increased lending profitability and a better borrower experience. "We selected Mortgage Cadence as our comprehensive mortgage solutions partner knowing they are committed to innovation and are dedicated to providing superior service to help us get the most out of our technology," said Tom Smith, president and CEO of TopLine Federal Credit Union. "We are excited to launch our new highly automated digital platform to provide our members an entirely paperless and seamless experience - from application through closing."
|
SMCI... | Hot Stocks12:03 EDT Super Micro drops after report that U.S. telecom found manipulated hardware - Shares of Super Micro Computer (SMCI) are plunging in New York following a report that a U.S. telecommunications company discovered manipulated hardware for Super Micro in its network and removed it in August. WHAT'S NEW: A "major" U.S. telecommunications firm found manipulated hardware from SMCI in its network and removed it two months ago, Bloomberg reports, citing Yossi Appleboum, a security expert working for the telecom company. Bloomberg did not identify the U.S. telecom in question due to Appleboum's nondisclosure agreement with the client. WHAT'S NOTABLE: The news follows a Bloomberg report from last week saying that Super Micro Computer was mentioned as being implicated in a Chinese scheme to spy on American companies, including Amazon (AMZN) and Apple (AAPL). The company "strongly" refuted the claims, saying that it has "never found any malicious chips, nor been informed by any customer that such chips have been found." PRICE ACTION: At midday, shares of Super Micro Computer trading in New York were lower by over 27% to $10.76.
|
HSBC | Hot Stocks12:03 EDT HSBC confirms $765M settlement with DOJ over RMBS claims - HSBC announced a definitive agreement with the US Department of Justice to resolve its multi-year investigation of its legacy securitization, issuance and underwriting of residential mortgage-backed securities issued between 2005 and 2007. "We are pleased to put this investigation related to activity that occurred more than a decade ago behind us," said Patrick J. Burke, President and Chief Executive Officer, HSBC USA. "Since the financial crisis, HSBC has been strengthening our culture, processes and internal controls to ensure fair outcomes for our clients. The US management team is focused on putting historical matters into the rear view mirror and completing the turn-around of HSBC's US operations." Under the terms of the agreement, HSBC North America Holdings Inc., without admitting liability or wrongdoing, will pay to the DOJ a $765M civil monetary penalty, of which $492M will be paid by HSBC USA Inc., HSBC North America's US-based public company. As previously disclosed, HSBC North America and HSBC USA Inc. were fully reserved for these amounts as of June 30, 2018. The settlement releases HSBC from potential civil claims by the DOJ related to its securitization, issuance and underwriting of RMBS during the period from 2005 through 2007, and requires no additional remedial action.
|
RDFN | Hot Stocks12:02 EDT Redfin names Daryl Fairweather Chief Economist - Redfin (RDFN) announced Daryl Fairweather, Ph.D., has joined its ranks as Chief Economist. Fairweather comes to Redfin from Amazon (AMZN), where she served as a senior behavioral economist, leading a team of analysts and economists focused on improving employee performance and engagement. In her new role at Redfin, Fairweather will contribute to the national conversation about the housing market and lead a team of Redfin economists and data scientists responsible for providing compelling reports on real estate market, homeownership, and the economic factors shaping where and why people are buying and selling homes.
|
LCA | Hot Stocks12:00 EDT Pelham Capital reports 14.2% passive stake in Landcadia
|
GOOG GOOGL | Hot Stocks11:50 EDT Google announces new Pixel Slate tablet, starting at $599 - Google announced the launch of its new Pixel Slate tablet and accessories, including a keyboard, at $199, and pen at $99. Comments provided during Made By Google event.
|
HSBC | Hot Stocks11:43 EDT HSBC pays $765M in settlement with DOJ over RMBS claims - Colorado U.S. Attorney Bob Troyer announced that HSBC will pay $765M to settle claims related to its packaging, securitization, issuance, marketing and sale of residential mortgage-backed securities between 2005 and 2007. During this period, federally-insured financial institutions and others suffered major losses from investing in RMBS issued and underwritten by HSBC, Troyer said in a statement. Under the settlement, HSBC will pay the $765M as a civil penalty pursuant to the Financial Institutions Reform, Recovery and Enforcement Act. Reference Link
|
HSBC | Hot Stocks11:42 EDT HSBC pays to $765M in settlement with DOJ over RMBS claims - Colorado U.S. Attorney Bob Troyer announced that HSBC will pay $765M to settle claims related to its packaging, securitization, issuance, marketing and sale of residential mortgage-backed securities between 2005 and 2007. During this period, federally-insured financial institutions and others suffered major losses from investing in RMBS issued and underwritten by HSBC, Troyer said in a statement. Under the settlement, HSBC will pay the $765M as a civil penalty pursuant to the Financial Institutions Reform, Recovery and Enforcement Act. Reference Link
|
PPG... | Hot Stocks11:39 EDT PPG slides after below-consensus outlook on rising costs, softening demand - Shares of PPG (PPG) are sliding after the company guided third and fourth quarter earnings below consensus, citing higher raw material costs and softening demand. Meanwhile, its peer Axalta Coating (AXTA) is also under pressure following the announcement that CEO Terrence Hahn has resigned amid an investigation by an outside counsel into his conduct unrelated to financial matters, which the company believes was inconsistent with its policies. PPG OUTLOOK: Last night, PPG said it sees third quarter adjusted earnings per share between $1.41-$1.45 and revenue of $3.8B, both below consensus of $1.59 and $3.88B, respectively. In a statement, CEO Michael McGarry said that, "In the third quarter, we continued to experience significant raw material and elevating logistics cost inflation, including the effects from higher epoxy resin and increasing oil prices. These inflationary impacts increased during the quarter and, as a result, we experienced the highest level of cost inflation since the cycle began two years ago. Also, during the quarter, we saw overall demand in China soften, and we experienced weaker automotive refinish sales as several of our U.S. and European customers are carrying high inventory levels due to lower end-use market demand. [...] Finally, the impact from weakening foreign currencies, primarily in emerging regions, has resulted in a year-over-year decrease in income of about $15M. This lower demand, coupled with the currency effects, was impactful to our year-over-year earnings and is expected to continue for the balance of the year." For the fourth quarter, PPG said it sees adjusted EPS between $1.03-$1.13, with consensus at $1.35. "We are anticipating continued raw material cost inflation in the fourth quarter, but at a more modest year-over-year rate given the inflation spike that occurred in the fourth quarter 2017," the CEO added. Commenting on the news, Deutsche Bank analyst David Begleiter told investors that while he had expected that the second half of 2018 would be challenging due to a combination of rising raw material costs, FX headwinds from stronger U.S. dollar and lower than expected auto OEM coatings demand, Q3 came in worse than expected. The analyst sees the announcement as disappointing, but reiterated a Buy rating on the shares as PPG is raising prices to offset rising raw material costs with price/cost parity likely to be achieved. PEER ALSO UNDER PRESSURE AFTER CEO CHANGE: Axalta Coating announced that its Board of Directors has appointed Robert Bryant, the company's EVP and CFO, to the additional role of interim CEO, effective immediately. Bryant succeeds Terrence Hahn, who resigned by mutual agreement with the board following an investigation by outside counsel into conduct by Hahn unrelated to financial matters that Axalta believes was inconsistent with company policies. Hahn has also vacated his position on the board. Axalta also announced that its preliminary results for its Q3 are in line with guidance communicated during its second quarter earnings update, which specified Q3 adjusted EBITDA of approximately 24% of the midpoint of its full-year range. Deutsche Bank's Begleiter told investors in a separate note that he views Axalta's preliminary results as a "solid positive" given several well-flagged headwinds facing U.S. coatings companies in the third quarter, including higher oil-based raw material costs, stronger U.S. dollar/FX, challenges achieving price at auto OEM customers, slightly lower than expected autos demand. The analyst believes Axalta was able to offset these headwinds with price increases and volume growth in Performance Coatings where Refinish volumes are growing following five straight quarters of declines stemming from working capital adjustments by distributors. He reiterated a Buy rating on the shares. PRICE ACTION: In late morning trading, shares of PPG have plunged about 8.5% to $100.22, while Axalta's stock has dropped nearly 7% to $26.67. Also lower, peer Sherwin-Williams (SHW) has slipped about 2.5% to $431.46.
|
EBAY | Hot Stocks11:21 EDT eBay strength continues as activist speculation resurfaces - Shares of eBay (EBAY) have moved higher after traders circulated chatter that an activist investor may be getting involved with the company. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly's news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved. The Fly has reached out to eBay for comment. Two weeks ago, TheDeal.com reported that several activists were "sniffing out" eBay, according to Bloomberg. Shares of eBay have risen $1.56, or 4.8%, to $34.14 in late morning trading.
|
DLTR | Hot Stocks11:13 EDT Dollar Tree revises 'change in control' retention pacts for certain executives - In a regulatory filing earlier, Dollar Tree disclosed that on October 3, the compensation committee of the board of directors adopted a revised form of the company's change in control retention agreement for certain executive officers, including named executive officers, that provides for a severance payment to the executive officer under certain circumstances in the event of a termination of employment following a change in control of the company. The revisions to the original form of change in control retention agreement update the tax provisions applicable to severance payments under the agreement and make certain other non-material clarifying and technical changes, the company stated. Such alterations to "change in control" terms are sometimes pointed to as cause for increased speculation about M&A, The Fly notes. In late morning trading, Dollar Tree shares are up $1.23, or 1.5%, to $83.51.
|
CPSI | Hot Stocks11:05 EDT American HealthTech announces partnership with QliqSOFT - American HealthTech, a wholly owned subsidiary of CPSI, and QliqSOFT are pleased to announce a partnership that will allow caregivers to use integrated Qliq Secure Texting. This partnership ensures text communications are secure and HIPAA compliant, which will give caregivers peace of mind and efficiency with patient-centered communications. AHT Communication Center, which is now generally available, contains four secure communication capabilities: text, email, chat and faxing. By utilizing Qliq secure text messaging, AHT caregivers can close the communication gap with integrated and secure texting.
|
BA | Hot Stocks11:04 EDT Boeing reports 190 commercial airplane deliveries in Q3 - Boeing announced deliveries across its commercial and defense operations for the third quarter of 2018. The company reports 190 commercial airplane program deliveries in Q3 and 568 year-to-date. In terms of Defense and Security, Boeing notes deliveries of 6 remanufactured AH-64 Apaches, 2 new and 6 renewed CH-47 Chinooks, 3 F-15 Models and 5 F/A-18 Models.
|
FOX FOXA | Hot Stocks11:03 EDT Fox appoints Rita Tuzon General Counsel, Jill Ratner as Chief Litigation Counsel - Fox (FOX, FOXA), the company to be spun-off in connection with 21st Century Fox's merger with Disney (DIS), announced that senior 21CF executives have been named to future leadership roles across legal and human resources. The appointments, which take effect upon close of the Disney transaction and the creation of the new FOX, were announced by Lachlan Murdoch, FOX Chairman and CEO. Rita Tuzon named FOX EVP and Corporate General Counsel; currently serves as EVP, General Counsel at Fox Networks Group; Jill Ratner will transition to FOX EVP and Chief Litigation Counsel; currently serves as EVP, Deputy General Counsel, Litigation at 21CF; Kevin Lord, currently EVP of HR at FOX News, will continue in that role but will broaden his responsibilities to provide HR oversight across all of FOX.
|
HSBC | Hot Stocks11:03 EDT HSBC Global Private Banking, iCapital Network partner for alternative offerings - HSBC Global Private Banking, Americas announced an agreement with financial technology firm iCapital Network to expand and streamline client access to alternative investments. The partnership is part of Global Private Banking's initiative to enhance investment management capabilities and expand its product offering for high-net-worth clients. iCapital will allow HSBC's qualified clients and their investment counsellors to evaluate and allocate to a broad range of private equity, private credit, and hedge fund investments. The platform offers access to: select fund managers who have previously worked almost entirely with institutional investors; a robust set of analytical tools and due diligence information to evaluate the investment merits of a given offering; and online investing at levels well below industry minimums of $5M+.
|
BAESY | Hot Stocks10:44 EDT U.S. Army to procure BAE's 155mm Bonus precision-guided munitions - The U.S. Army is adding BAE Systems' Bofors 155mm BONUS ammunition to its arsenal, through a contract with the NSPA. "Already qualified by the Army, the latest version of BONUS defeats heavily armored targets and can be fired from any 155-millimeter artillery system, including M777 lightweight towed howitzers and the M109 self-propelled howitzer family of vehicles," BAE says. Work under this contract will begin immediately, with deliveries scheduled to take place through 2020. In addition to the United States, several other countries operate BONUS, including Finland, France, and Norway, and Sweden.
|
CMCSA... | Hot Stocks10:39 EDT Comcast says acceptance condition for mandatory offer for Sky satisfied - Comcast (CMCSA) announces that it has completed the acquisition of Sky (SKYAY) shares held by 21st Century Fox (FOXA) and the acceptance condition to its mandatory offer for Sky has now been satisfied. Accordingly, the mandatory offer has become unconditional as to acceptances and, as the condition was the only condition to the mandatory offer, the mandatory offer is also wholly unconditional. Accordingly, as at 1:00 pm London time on October 9, Comcast Bidco may count 1,365,573,329 Sky shares, representing over 75% in aggregate of Sky's issued ordinary share capital, towards satisfaction of the condition to the mandatory offer. Comcast Bidco will now procure that Sky makes applications to cancel the listing of Sky shares on the UK Listing Authority's Official List and to cancel trading in Sky shares on the London Stock Exchange's Main Market for listed securities. It is anticipated that cancellation of Sky's listing on the Official List and admission to trading on the London Stock Exchange's Main Market will take effect no earlier than 20 business days after the date of this announcement. Comcast Bidco therefore confirms that the notice period has commenced and that the anticipated date of cancellation is November 7.
|
GIB | Hot Stocks10:32 EDT CGI Group to create 300 high-tech jobs in Drummondville over next five years - CGI is pleased to announce that it will open a center of excellence in the city of Drummondville, within the Centre-du-Quebec region, before the end of the year. CGI is planning to create approximately 300 high-tech jobs over the next five years within the center, which will specialize in digital transformation and innovation and primarily target the finance, retail and manufacturing sectors. Through the new center, CGI's clients will realize the benefits of cutting-edge expertise and next-generation technological solutions to step up their shift to digital and adapt to emerging trends. CGI's new center in Drummondville is part of a worldwide network of centers of excellence that focus on key markets and technologies. Through each of these centers, CGI works closely with clients and partners to design leading-edge solutions and services that support our clients' digital transformation, performance, results and growth. The new Drummondville center of excellence is CGI's seventh in Quebec, in addition to centers in Saguenay, Sherbrooke, Quebec City, Shawinigan, Montreal and Gatineau. Within the province, CGI has a network of 7,500 professionals.
|
WMT... | Hot Stocks10:25 EDT Deutsche Bank says buy Walmart, sell Kroger as grocery landscape shifts - This morning, Deutsche Bank analyst Paul Trussell downgraded Kroger (KR) to Sell while upgrading Walmart (WMT) to Buy. The analyst argued that its strategies will likely be significantly more costly than Kroger and consensus are currently forecasting. On the other hand, Trussell believes Walmart is now in position to accelerate market share gains in grocery while also growing EBIT dollars and expanding its return on investment. SELL KROGER: In a research note to investors this morning, Deutsche Bank's Trussell downgraded Kroger to Sell from Hold and lowered his price target on the shares to $24 from $30. Kroger's strategy to aggressively expand e-commerce capabilities, optimize space within its current footprint, and compete on price "will likely be significantly more costly" than the company and consensus are currently forecasting, he contended. While the analyst noted he is "on board" with the majority of steps that management has outlined as part of its Restock Kroger plan, and believes that the company may be one of the winners in food retail over the long-term, Trussell pointed out that it will likely be "quite challenging" to grow profits as it plays "from a position of weakness." Consequently, he is now modeling operating income falling well short of current targets. Further, the analyst argued that he sees areas where Kroger may need to get more aggressive and speed up its pace of investments, such as grocery pickup or the Ocado partnership. Second quarter results were a "major warning flag" and suggest that 2018 earnings per share is at risk, while the shares still trade at an above-average premium, albeit down from recent highs, he added. BUY WALMART: In a separate note, Deutsche Bank's Trussell upgraded Walmart to Buy from Hold and raised his price target on the shares to $113 from $89. The analyst told investors that the retailer is reaping returns on the many years of investment in e-commerce and customer service, and that he believes Walmart is now in position to accelerate market share gains in grocery while also growing EBIT dollars and expanding return on investment. Moreover, Trussell noted that channel checks suggest continued sales momentum and ongoing improvements in execution. Overall, Trussell said he believes Walmart's portfolio of assets is differentiated in the "rapidly changing" retail landscape. Heading into the upcoming Investment Community Meeting, the analyst expects management to sound bullish, particularly around trends in the U.S. business, reiterating the 40% growth for the U.S. online business for the current year, with a target of about 30% in FY19. Trussell also expects the online conversation to shift to a global level as Walmart is now the 77% owner of the largest player in the Indian e-commerce market. Wage pressure should persist in FY19, he contended, given the tight labor market and competitors moving up their wage rates. However, the analyst noted he does not expect the retailer to match Amazon's (AMZN) $15/hour minimum wage rate as the employees impacted by Amazon's wage raise are mostly in distribution centers and Whole Foods locations are in urban centers where wages are above Walmart's $11/hour. PRICE ACTION: In morning trading, shares of Walmart have gained about 1% to $95.53, while Kroger's stock has dropped over 6% to $27.50.
|
EXPR | Hot Stocks10:12 EDT Express to introduce NBA-licensed collection in November - Express announced Express's multiyear expanded partnership with the NBA. Additionally, Express unveiled its second "NBA Game Changers" campaign and Performance Collection featuring NBA All-Star Victor Oladipo, Mo Bamba and Trae Young, two of this year's top NBA Draft picks, as well as current NBA stars John Collins and Jamal Murray. Express will also introduce an NBA-licensed collection in November 2018 with a robust assortment of men's apparel available in-store in select markets and online at express.com. The line will tip off with an array of men's graphic tees and fleece styles, and will expand to additional product categories including blazers, dress shirts, ties, and underwear in 2019. The retailer will also introduce a women's collection in 2019. The integrated marketing and advertising campaign will premiere across Express's digital, social media, and in-store platforms as well as the NBA's digital and social media platforms beginning this month.
|
NYMX | Hot Stocks10:03 EDT Nymox: Gleason grade progression reduced by 81% in FT Phase IIb trial - Nymox Pharmaceutical announced new long-term clinical trial results from the company's 146 patient Phase IIb NX03-0040 Fexapotide U.S. study for low grade localized prostate cancer. All patients in the 78 month study had greater than or equal to 56 months from the time of enrollment, with a range of 56 to 78 months. After 78 months, the data shows that men who received the high dose Fexapotide 15mg single dosage treatment had a 73% reduction in the need for surgery or radiotherapy associated with much more favorable biopsy Gleason results compared to controls. There were 5% patients in the entire Fexapotide group who showed increase in their Gleason primary pattern grade in the 78 month study, compared to controls where the incidence of grade 4 or higher primary pattern was 26.3%, a reduction of 81%. In the low grade localized prostate cancer trial reported today, Fexapotide triflutate was administered by a single painless injection directly into the prostate in a simple procedure requiring several minutes or less in an office setting without sedation or anesthesia, and guided by routine ultrasound. FT was injected into the area of the prostate where the cancer was previously detected prior to enrollment in NX03-0040. The patients were then biopsied after 6 weeks and then every 18 months, along with serial PSA measurements and long-term follow-up. After 78 months of study, high dose FT 15mg single treatment resulted in 73% less surgery or radiotherapy associated with Gleason grade progression, and both doses of FT as a group were overall effective. The 15mg dose was more effective than the lower dose. There were 5% patients in the entire FT group who showed increase in their Gleason primary pattern grade in the 78 month study, compared to controls where the incidence of grade 4 or higher primary pattern was 26.3%, a reduction of 81%.
|
LGND | Hot Stocks10:02 EDT Sermonix Pharmaceuticals launches Phase 2 trial to evaluate oral lasofoxifene - Sermonix Pharmaceuticals announced the launch of a Phase 2 trial for the treatment of metastatic breast cancer. The program is an open-label, randomized, multi-center study evaluating the activity of its lead investigational drug, oral lasofoxifene, versus intramuscular fulvestrant for the treatment of postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation. Linical Accelovance Group, a mid-size global contract research organization, will serve as Sermonix's research partner for the study, enrolling 100 patients in 27 sites across the U.S. The trial will utilize oral lasofoxifene for advanced breast cancer patients with ESR1 gene mutations. The primary clinical endpoint will be progression-free survival. Lasofoxifene is an investigational, nonsteroidal selective estrogen receptor modulator, which Sermonix licensed from Ligand Pharmaceuticals.
|
AFMD RHHBY | Hot Stocks10:02 EDT Affimed plunges after drug program put on hold following patient death - Shares of Affimed (AFMD) plunged in morning trading after the company suspended trials on a cancer drug following the death of a patient. The company also said two other patients suffered "life-threatening events." DRUG TRIAL SUSPENSION: Affimed on Monday said it had placed studies of AFM11, its experimental cancer drug, on clinical hold following the death of a patient in its acute lymphoblastic leukemia trial and two life-threating events in its non-Hodgkin lymphoma study. Thirty three patients have been treated in the two early stage studies, the company said. Affimed also said it will be working closely with the global health authorities, the Safety Monitoring Committees, and the studies' clinical investigators to review the events, assess all of the data and determine its next steps for the AFM11 program. The clinical hold will not impact the ongoing development of Affimed's NK cell engager programs, which are based on targeting the NK cell receptor CD16A, a different approach than used for AFM11, which targets T cells through CD3, it noted. ANALYST COMMENTARY: BMO Capital analyst Do Kim told investors in a research note that he believes the clinical hold on AFM11 will likely be temporary, as the three "severe adverse events" cited in the hold were identified as neurotoxicities. Kim, who has an Outperform rating and $5 price target on Affimed shares, lowered his probability of success in ALL to 25% from 30% and kept his probability in NHL at a "low" 15%. He recommends investors buy Affimed shares on weakness since the clinical hold is not likely to become "program ending." SunTrust analyst Peter Lawson lowered his price target on Affimed shares to $5 from $7, but maintained a Buy rating, telling investors in a research note of his own that he sees no read-through to the company's NK cell engager platform, nor does he see any impact on the recent NK cell engager Genentech (RHHBY) deal. Lawson contended that commentary from the management indicates that the "series adverse events" in the study hold are "likely drug-related and from a CD19-related neurotoxicity" and should not impact the ongoing development of AFM13. PRICE ACTION: In morning trading, shares of Affimed declined nearly 30% to $3.39.
|
DDR | Hot Stocks10:01 EDT DDR Corp. to change name to 'SITE Centers' - DDR Corp. announced plans to change its name to SITE Centers Corp. as well as a change to the ticker symbol for common and preferred stock on the New York Stock Exchange ticker to "SITC" from "DDR" effective with the opening of trading on October 12, 2018.
|
CADC | Hot Stocks09:55 EDT China Advanced Construction trading resumes
|
WLBA WMLP | Hot Stocks09:48 EDT Westmoreland Coal enters into restructuring support pact, files Chapter 11 - Westmoreland Coal (WLBA) announced it has entered into a restructuring support agreement with members of an ad hoc group of lenders that hold approximately 76.1% of the company's term loan, approximately 57.9% of its senior secured notes, and approximately 79.1% of its bridge loan. To implement the RSA, Westmoreland filed voluntary petitions for relief under chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division. In addition, Westmoreland affiliate Westmoreland Resource Partners (WMLP) simultaneously filed for relief under chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division. WMLP has agreed to terms with its secured creditors on the use of cash collateral to fund WMLP's normal course operations and allow WMLP to serve its customers during the course of WMLP's chapter 11 case. WMLP intends to continue working constructively with an ad hoc group of its secured lenders in connection with a value-maximizing sale and marketing process that began prior to the commencement of WMLP's chapter 11 case. Under the RSA, the Ad Hoc Group has agreed to act as a stalking horse bidder to acquire substantially all of Westmoreland's business assets. Separately, WMLP will continue its sale process. The RSA addresses Westmoreland's liabilities, including funded debt and other obligations, and provides the means for it to continue operating in the normal course of business. Both Westmoreland and WMLP have filed "first day" motions with the Bankruptcy Court. When granted, these motions will enable day-to-day operations, regular payment of employee wages and benefits, and payment to key trade creditors for goods and services provided on or after the filing date to continue as usual.
|
PPG | Hot Stocks09:47 EDT PPG falls -8.5% - PPG is down -8.5%, or -$9.35 to $100.23.
|
CISN | Hot Stocks09:47 EDT Cision falls -6.3% - Cision is down -6.3%, or -$1.01 to $14.91.
|
TTM | Hot Stocks09:47 EDT Tata Motors falls -12.1% - Tata Motors is down -12.1%, or -$1.74 to $12.62.
|
GCAP | Hot Stocks09:47 EDT Gain Capital rises 7.8% - Gain Capital is up 7.8%, or 54c to $7.45.
|
GSC | Hot Stocks09:47 EDT Global Geoscience rises 9.7% - Global Geoscience is up 9.7%, or $2.74 to $30.97.
|
PYX | Hot Stocks09:47 EDT Pyxus rises 20.2% - Pyxus is up 20.2%, or $7.77 to $46.29.
|
VUZI | Hot Stocks09:46 EDT Vuzix receives M300 Smart Glasses follow-on order from SATS - Vuzix Corporation announced that the company has received an approximately $1M commercial M300 Smart Glasses follow-on order from SATS to outfit SATS' ramp handling operations at the Changi Airport in Singapore. SATS, the chief ground-handling and in-flight catering service provider at Singapore Changi Airport, started piloting the Vuzix M300 Smart Glasses to digitize its ramp handling operations in mid-2017 and is now completing phase 2 by introducing and deploying the technology to more than 500 staff at Changi Airport. Using Vuzix M300 Smart Glasses, SATS ramp handling staff will now be able to scan barcodes on baggage and cargo containers to improve the baggage handling process.
|
KELYA | Hot Stocks09:28 EDT Kelly Services announces strategic partnership with iteach - Kelly Educational Staffing announced a strategic partnership with iteach, a teacher certification program. This exclusive partnership is the first of its kind to establish a consistent, long-term solution to the nationwide teacher shortage by placing qualified individuals in the teaching profession through a unique alternative approach. Founded in 2003, iteach offers a unique online coursework format and accreditation for individuals who have a four-year degree. While completing the iteach certification program, individuals will participate in a one-year, two-semester paid residency during which time they are employed full-time as a teacher in their chosen field of study. With this partnership, KES will be able to offer iteach's certification process to qualified candidates from their education talent pool as well as to the broader pool of Kelly Services.
|
PZZA... | Hot Stocks09:25 EDT Fly Intel: Pre-market Movers - HIGHER: Papa John's (PZZA), up 6% after after WSJ reports Trian weighing possible takeover bid... Ziopharm (ZIOP), up 3% after announcing new definitive license agreement with Intrexon (XON) subsidiary Precigen... Gain Capital (GCAP), up 6.5% after commencing a $50M modified Dutch auction tender offer... Ebix (EBIX), up 6% after announcing a target of annual revenue of over $650M for FY19. UP AFTER EARNINGS: Helen of Troy (HELE), up 7%. LOWER: PPG (PPG), down 8% after guiding Q3 and Q4 earnings below consensus on higher raw material costs... Blackbaud (BLKB), down 20% after cutting FY18 guidance... Affimed (AFMD), down 27% after suspending a phase 1 trial following the death of a patient... Kroger (KR), down 2% after Deutsche Bank analyst Paul Trussell downgraded the stock to Sell from Hold and lowered his price target for the shares to $24 from $30. Kroger's strategy to aggressively expand e-commerce capabilities, optimize space within current footprint, and compete on price "will likely be significantly more costly than the company and consensus are currently forecasting," Trussell tells investors... Trevena (TRVN), down 63% after the FDA posted briefing documents ahead of an upcoming advisory committee meeting to review the safety and efficacy of Trevena's oliceridine.
|
OHGI | Hot Stocks09:25 EDT One Horizon Group acquires intellectual property rights for 123Wish platform - One Horizon Group reported that it has entered into an agreement that grants the company an 80% ownership interest in the software and source code and all other intellectual property underpinning the 123Wish experience marketplace platform. In accordance with the terms of the transaction, the company will grant a perpetual license in furtherance of the continuation of the 123Wish experience marketplace, which is majority-owned by OHGI, and has been growing in popularity; this past month 123Wish saw nearly 500% growth in important metrics including Sessions, Users, and Pageviews. 123Wish Management plans to augment its existing business by entering into revenue-share or other licensing agreements to make the 123Platform available to social media influencers and all forms of entertainment artists. OHGI will focus on other opportunities to license the 123Platform as licensor or in conjunction with co-branded credit card and digital payment systems programs.
|
HIL | Hot Stocks09:18 EDT Hill International receives contract from City of Columbus division - Hill International announced it received a contract to provide construction management services in support of a Capital Improvement Program for the City of Columbus' Department of Public Utilities, Division of Water. The Division expects the Program to include more than 25 projects totaling more than $130M. These projects could include water treatment plant upgrades, reservoir repairs and improvements, hydroelectric dam improvements, well pump replacements, security improvements, and miscellaneous facilities modifications, including HVAC, roof, and security upgrades.
|
PTE | Hot Stocks09:17 EDT PolarityTE: Regulatory bodies notified of suspected illegal trading in stock - PolarityTE announced that multiple regulatory bodies are being notified of suspected significant illegal trading in the company's securities. Such activities appear to be in strategic coordination with the publication of misleading materials. These activities have brought damages to the Company and the Company's shareholders. After this information was brought to the Company's attention, the Financial Industry Regulatory Authority was notified. At this time, it appears that a variety of documented trades, conducted by external entities, were specifically orchestrated to coincide with the publication of speculative and misleading information about PolarityTE. Detailed notifications of such documented activities are also being submitted to Nasdaq and the SEC. For example, some of the recent trades that raised concerns about intentional market manipulation and illegal trading activity occurred from October 1 through October 3, 2018 between prices of $19.74 and $18.00 per share, with unusual volume and timing that coincided with the market close on October 1, 2018 and the market opens on October 2 and October 3, 2018. These block trades appear to have been timed in coordinated manners, directed at certain prices, and are not representative of volume-weighted average price trading.
|
PFE | Hot Stocks09:16 EDT Pfizer names Lidia Fonseca chief digital and technology officer - Pfizer announced its executive team that will report to Albert Bourla, incoming CEO, coincident with the commencement of his new role effective January 1, 2019. Frank D'Amelio, CFO and EVP, Global Supply and Business Operations, will also assume the leadership for manufacturing operations, Pfizer Global Supply. Mikael Dolsten, global president, Worldwide Research and Development, and Medical, will also assume oversight of the chief medical officer's role. Michael Goettler, global president, Established Medicines will lead the Established Medicines business that will operate as an autonomous, stand-alone unit within Pfizer. Angela Hwang , group president, Pfizer Innovative Medicines, will become the group president of Pfizer's science-based Innovative business responsible for the entire portfolio of innovative medicines. Rady Johnson, EVP, chief compliance, quality and risk officer, will continue in his role as the company's chief compliance officer. Doug Lankler, EVP, general counsel, will continue in his role as the company's general counsel. Freda Lewis-Hall, EVP, chief patient officer, will assume a new role as Pfizer's chief patient officer, deploying the resources of the company to advocate on behalf of all patients who rely on Pfizer to deliver new therapies and vaccines. Rod MacKenzie, EVP, chief development officer, will expand his responsibilities to include Pfizer's regulatory affairs function in addition to all late stage development activities. Dawn Rogers, EVP, chief human resources officer, will continue to lead the Human Resources team. Sally Susman, EVP, chief corporate affairs officer, will continue to lead the Corporate Affairs function. John Young, group president, chief business officer, will assume a new role, responsible for strategy, business development, portfolio management and valuation activities; business analytics; global commercial operations; and Patient and Health Impact, among others. Pfizer's Consumer Healthcare business will also report to John. Given the growing strategic importance of deploying digital technologies in research, discovery and business processes, Pfizer is appointing a chief digital officer responsible for creating and implementing a strategy that accelerates and improves digital capabilities to deliver more value to patients. Lidia Fonseca will join Pfizer's Executive Leadership Team in January 2019, as EVP, chief digital and technology officer. She is currently the chief information officer and SVP at Quest Diagnostics. EVP and president, PGS, Kirsten Lund-Jurgensen, will retire at the end of the year after 19 years at Pfizer, and EVP, Strategy & Commercial Operations, Laurie Olson, will retire effective January 1, 2019, after 32 years at Pfizer.
|
ZKIN | Hot Stocks09:16 EDT ZK International Group selected as supplier by Zhuhai Water Environment Holding - ZK International Group announced that the Company has been chosen by Zhuhai Water Environment Holding Group as a leading supplier of stainless steel piping for updating the water supply infrastructure in Zhuhai, China. Zhuhai is a city on the southern coast of Guangdong province in China, located in the Pearl River Delta that borders Hong Kong and Macau.
|
FLGT | Hot Stocks09:09 EDT Fulgent Genetics and StemCyte announce new partnership - StemCyte and Fulgent Genetics announce a new partnership to offer comprehensive genetic testing to support the health of growing families. Two genetic tests, "Beacon Expanded Carrier Screening" and "Newborn Genetic Analysis," will now be offered through StemCyte and powered by Fulgent Genetics. Beacon Expanded Carrier Screening can help identify potential reproductive risks for current or future pregnancies.
|
JACK | Hot Stocks09:08 EDT National Jack in the Box Franchisee Association calls for CEO resignation - The National Jack in the Box Franchisee Association announced it has called for the current Jack in the Box CEO, Leonard Comma, to step down and relinquish his position as CEO, and for the board to replace the current leadership team. This call is the aftermath of a majority vote of 'No Confidence' from the association's members at its annual meeting held in July. The membership of the National Jack in the Box Franchisee Association is comprised of 95 franchisees representing the ownership of approximately 2,000 restaurants out of a system-wide total of approximately 2,240 restaurants. "The vote of 'No Confidence' is the culmination of years of long-ranging discussions and unanswered concerns brought directly to Jack in the Box CEO Lenny Comma," said Michael Norwich, NFA Board Chairman. "We have reached out in every possible manner to communicate our concerns to the leadership and the current board of directors by offering meetings, conducting our own surveys of the franchise system, and proposing various solutions to the issues facing our system." Norwich continued, "Following an extended period of time that was characterized by a lack of effective reaction by Jack in the Box leadership to remedy our expressed concerns which include among other things, a severe lack of corporate resources being devoted to providing service, support, assistance and marketing to the franchisee community and which have caused an unsustainable loss in sales and transactions, our membership has cast a vote of 'No Confidence' in the executive leadership at Jack in the Box and are asking for immediate response and action by the company's Board of Directors." The membership of the association tasked its leadership with communicating its 'No Confidence' vote to the Jack in the Box Board of Directors, after which Jack in the Box Board of Directors hired an independent outside counsel to investigate the 'No Confidence' issues. The association also identified a number of key areas of concern that the Board of Directors must focus on and set forth proposed solutions to each of these issues. These action items and proposed solution were detailed in a letter sent to the Board of Directors. The NFA has received no response. The association membership concerns expressed in the letter are laser-focused toward the implementation of strategic measures that will positively impact the business and drive transaction, traffic and check average.
|
RICK | Hot Stocks09:08 EDT RCI Hospitality reports Q4 same stores sales $37.7M vs $36.9M last year - RCI Hospitality Holdings announced total and same-store sales for its Nightclubs and Bombshells restaurant segments for the Q4 and FY18. The company expects to report complete 4Q18 and FY18 results on or before December 14, 2018. Q4 of FY18 and Q4 of FY17 highlights include:Total club and restaurant sales $39.4M compared to $38.1M; consolidated same-store sales $37.7M compared to $36.9M; nightclubs sales $33.8M compared to $32.6M; bombshells sales $5.5M compared to $5.6M. FY18 vs. FY17 highlights include: total club and restaurant sales $163.0M compared to $142.4M; consolidated same-store sales $144.8M compared to $138.4M; nightclubs sales $138.9M compared to $123.6M; and bombshells sales $24.1M compared to $18.8M.
|
TEVA | Hot Stocks09:07 EDT Celmatix, Oncotest-Teva announce commercial agreement for Fertilome test - Celmatix has announced a commercial agreement with Oncotest-Teva, a subsidiary of Teva Pharmaceutical Industries, in Israel to bring the Fertilome test, the world's first multigene panel test for a woman's reproductive health and fertility, to the Israeli market. This partnership represents the first strategic international collaboration for Celmatix and will make the Fertilome genetic test widely available to women through their doctors in Israel. With the Fertilome test, Celmatix is ushering in a new era of personalized medicine in reproductive health. With this collaboration, the company is taking that movement global. A simple blood test ordered by a doctor, the Fertilome test can empower women to be more proactive about their family building by revealing whether they have genetic markers that have been associated with fertility-affecting conditions such as recurrent pregnancy loss, primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.
|
JACK | Hot Stocks09:07 EDT National Jack in the Box Franchisee Association calls for CEO resignation
|
WMLP | Hot Stocks09:07 EDT Westmoreland LP trading halted, news pending
|
CMTL | Hot Stocks09:06 EDT Comtech awarded $1.2M multi-year contract extension by U.S. wireless carrier - Comtech Telecommunications announced , that during its first quarter of fiscal 2019, its Safety & Security Technologies group, which is part of Comtech's Commercial Solutions segment, was awarded a multi-year contract extension totaling $1.2 million to provide FCC mandated enhanced 911 services to New-Cell, Inc. dba Cellcom. As part of this contract extension, Comtech will also provide emergency call routing services for Cellcom's Voice Over Long Term Evolutions and Voice over WiFi networks.
|
MDLZ | Hot Stocks09:05 EDT Mondelez announces commitment to making all packaging recyclable by 2025 - Mondelez announced a new commitment to make all packaging recyclable and provide recycling information by 2025. The company will work in partnerships so that packaging can be collected and recycled in markets around the world. This new commitment is part of the company's strategy for a circular packaging economy and will help deliver its long-term vision for zero-net waste packaging.
|
OSTK | Hot Stocks09:04 EDT Overstock.com announces inaugural 'Customer Day' on October 15 - Overstock.com announces its inaugural Customer Day is on October 15 during its annual Anniversary Sale. Overstock says it will offer "one day of savings with discounts on more than 1.5 million products, making this the largest number of products Overstock has ever discounted during a single sale... Customer Day will feature deals on an assortment of products that have never before been discounted -- including new products and highest rated favorite -- across multiple categories, including area rugs, bedding, and all home decor. In addition, Overstock will discount its exclusive private label brands."
|
MMS GD | Hot Stocks09:04 EDT Maximus to acquire U.S. Federal citizen engagement centers for $400M in cash - MAXIMUS (MMS) announced that it has signed a definitive asset purchase agreement to acquire certain assets of General Dynamics (GD) Information Technology's large-scale, citizen-engagement centers in the U.S. Federal civilian market. The acquisition is expected to strengthen MAXIMUS position in the administration of federal government programs across the United States. The $400M all cash transaction is expected to close in mid-November and is subject to customary closing conditions. This acquisition is a natural fit for MAXIMUS and expands its reach in the delivery of citizen services. The acquisition enables greater economies of scale and brings enhanced technology and added operational capabilities that will benefit the entire MAXIMUS portfolio. The associated assets included in the asset purchase agreement had revenue of approximately $670 million for the twelve months ended June 2018. This revenue is primarily tied to cost reimbursable contracts and accordingly, operating margins typically average in the mid-single digit range. MAXIMUS expects that the transaction will close in mid-November, subject to customary closing conditions. MAXIMUS currently anticipates that the assets associated with this transaction will generate approximately 10.5 months of revenue for its fiscal year 2019 in the range of $575 million to $600 million. The transaction is expected to be accretive by $0.10 to $0.15 of diluted earnings per share in fiscal year 2019 after consideration of one-time expenses, interest, non-cash charges, and cost synergies.
|
LULU | Hot Stocks09:03 EDT Lululemon not to expunge RYU trade-mark registrations issued by CIPO - RYU Apparel announced that it has successfully protected its registration over its RYU trade-mark registrations in Canada, including the RYU logo. The Company also has trade-mark registrations in the U.S., China and Hong Kong. Lululemon Athletica has advised that it does not intend to expunge any RYU trade-mark registrations of the Company that may be issued from the Canadian Intellectual Property Officer, or CIPO, including the RYU trade-mark or oppose the current trade-mark applications for the RYU Marks. The legal matter started in March 2017 after the Company advertised its application for the RYU trade-mark on the January 2017 edition of the Trade-marks Journal and Lululemon sought and received and extension from CIPO to consider whether to oppose the RYU Marks, having produced a T-shirt prominently featuring the letters RYU, even though the Company was already operating with multiple stores and a growing international e-commerce business.
|
MMS GD | Hot Stocks09:03 EDT Maximus to acquire U.S. Federal citizen engagement centers for $400M in cash - MAXIMUS (MMS) announced that it has signed a definitive asset purchase agreement to acquire certain assets of General Dynamics (GD) Information Technology's large-scale, citizen-engagement centers in the U.S. Federal civilian market. The acquisition is expected to strengthen MAXIMUS position in the administration of federal government programs across the United States. The $400M all cash transaction is expected to close in mid-November and is subject to customary closing conditions. This acquisition is a natural fit for MAXIMUS and expands its reach in the delivery of citizen services. The acquisition enables greater economies of scale and brings enhanced technology and added operational capabilities that will benefit the entire MAXIMUS portfolio.
|
BLPH | Hot Stocks09:00 EDT Bellerophon provides update on Phase 2b iNO-PF study - Bellerophon provided an update on the company's ongoing Phase 2b randomized, double-blind, placebo-controlled clinical study, or iNO-PF, evaluating INOpulse in patients with Pulmonary Hypertension associated with Interstitial Lung Disease, or PH-ILD, as well as updated interim results from the Pulmonary Arterial Hypertension, or PAH, Phase 3 trial, INOvation-1. Bellerophon has completed enrollment of the planned 40 subjects in the iNO-PF trial, with top-line results for this cohort expected in January 2019. These subjects are randomized to iNO 30 vs. placebo, with a one-week run-in period, followed by an eight-week double-blinded treatment period. Following completion of the blinded treatment period, subjects are offered open-label access. The study is evaluating multiple endpoints, including change in six-minute walk distance, oxygen saturation, right ventricular function, activity monitoring, patient reported outcomes, as well as several composite endpoints. In order to support a potential registration package, the company will expand the iNO-PF study to assess higher doses of iNO and duration of treatment through the addition of two further cohorts. Cohort 2 will include approximately 20 subjects randomized to receive either iNO 45 or placebo. Cohort 3 will include approximately 20 subjects randomized to receive either iNO 75 or placebo. In addition to evaluating higher doses, cohorts 2 and 3 will increase the blinded treatment period from 8 weeks to 16 weeks. Enrollment in these additional cohorts is expected to begin later this year, with top-line data anticipated in 2019. In addition to the further cohorts, the study is also being modified to allow dose escalation during the open-label period.
|
CADC | Hot Stocks08:55 EDT China Advanced Construction trading halted, news pending
|
TRVN | Hot Stocks08:53 EDT Trevena plunges after oliceridine committee meeting documents posted - Shares of Trevena are under pressure ahead of the open after the FDA posted briefing documents ahead of an upcoming advisory committee meeting to review the safety and efficacy of Trevena's oliceridine, the first of a new class of micro-opioid receptor ligands designed to optimize MOR pharmacology with the goal of delivering the pain relief of a conventional intravenous opioid with fewer opioid-related adverse events, or ORAEs. The documents state: "In terms of efficacy, all oliceridine regimens met the primary endpoint in both pivotal Phase 3 studies, meeting FDA's efficacy requirement for approval." A summary section also states: "A HAL study demonstrated that oliceridine was associated with similar drug liking to equianalgesic doses of morphine. These findings support Trevena's proposal that, if approved, oliceridine should be designated a Schedule II drug under the Controlled Substances Act, which would provide the same controls and precautions that currently exist for conventional IV opioid medications...While the Phase 3 studies were ultimately underpowered for the statistical evaluation of the novel composite measure of RSB, a comprehensive appraisal of the respiratory safety data provides evidence that oliceridine attenuates the respiratory impact of an IV opioid. While clinically differentiated from morphine, the current data are not sufficient to warrant a formal labeling claim of safety superiority to conventional opioid therapy." The summary section concludes: "Overall, oliceridine has a favorable benefit/risk profile for its intended use in a controlled clinical setting and would provide physicians with a valuable treatment option for patients who require IV opioid therapy." In pre-market trading, Trevena shares have plunged $1.53, or 51%, to $1.45. Reference Link
|
ABUS | Hot Stocks08:51 EDT Arbutus Biopharma appoints Gaston Picchio CDO - Gaston Picchio has joined Arbutus as CDO from Janssen R&D, bringing with him over thirty years of basic and clinical experience in the field of human virology, and sixteen years of industry experience dedicated to the development of antiviral drugs including drug approvals for the treatment of HIV and HCV. Prior to joining Arbutus, Picchio served in various senior management positions at Janssen R&D.
|
ABUS | Hot Stocks08:49 EDT Arbutus Biopharma provides update on HBV development programs - Arbutus Biopharma provided an update on its key HBV development programs. AB-506, the company's second generation capsid inhibitor, has progressed through the healthy volunteer portion of a multi-component phase 1a/1b study in which it was demonstrated to be generally safe and well-tolerated after 10 days of dosing. This month, AB-506 will enter the 28-day HBV patient portion of the trial, where it will be evaluated both with and without a nucleoside analog. AB-452 is a novel, orally available RNA-destabilizer that has shown compelling anti-viral effects in multiple preclinical models. AB-452 is a new chemical entity acting via a novel mechanism and the company is taking the time needed to further characterize the compound following emerging nonclinical safety findings before initiating clinical studies. At present, this is expected to delay the initiation of the phase 1 program while the company completes the ongoing nonclinical studies. ARB-1467, an RNAi agent targeting HBV replication and antigen production, is currently in a 30-week study in HBV patients, in combination with tenofovir and PEG-IFN. To date, six HBV patients have enrolled and been treated. Three patients did not meet the predetermined response criteria at week 6 to proceed to PEG-IFN treatment as per protocol. Two patients have not yet progressed to the six-week analysis point to determine if the addition of PEG-IFN is warranted. One patient has responded strongly, with a 3.17 log reduction in HBsAg level at treatment week 14 of under 4 IU/mL having started with a baseline level of greater than 6000 IU/mL, indicating that this regimen may drive HBsAg levels to undetectable in some patients. The study remains open to enrollment and the company will provide periodic updates. AB-729. Arbutus is developing a second-generation RNAi agent, AB-729, a subcutaneously-administered GalNAc conjugate, targeting HBV. In preclinical models AB-729 exhibits potent and durable reductions in HBsAg. This agent is expected to enter clinical studies in Q2 2019 and may be combined with AB-506 in a clinical study in 2H 2019.
|
STRL | Hot Stocks08:48 EDT Sterling awarded $17M contract by Los Angeles County Sanitation District - Sterling Construction Company announced that Myers & Sons Construction, a consolidated affiliate, was awarded a contract by the Los Angeles County Sanitation District for additions and modifications to their Valencia Water Reclamation Plant in Valencia, CA. This $17M project entails the addition of Ultraviolet Disinfection Facilities and ancillary systems that would allow for further treatment of the influent wastewater. In addition, Myers' work consists of a ground-up installation of several concrete structures, including a Flow Diversion Structure, UV Wetwell, UV Reactor Basin, and multiple junction structures. Construction is anticipated to start in November of 2018 and take approximately 24 months to complete.
|
ESRX | Hot Stocks08:47 EDT Express Scripts introduces Medicare Prescription Drug Plan offerings for 2019 - Express Scripts introduced its Express Scripts Medicare Prescription Drug Plan, or PDP, offerings for 2019, offering seniors three high-value options for coverage and savings. The company's popular, low-premium Saver plan, which made its debut in 2018, will continue to provide affordable access to more than 2,800 commonly used medications while offering an expanded preferred pharmacy network that will now include Walmart in addition to CVS Pharmacy and the Kroger Family of Pharmacies.
|
ORIG RIG | Hot Stocks08:47 EDT Ocean Rig sets date of extraordinary meeting to approve merger with Transocean - Ocean Rig UDW (ORIG) announced that it has scheduled an extraordinary general meeting of shareholders to, among other things, consider and vote on a proposal to approve and adopt the previously announced Agreement and Plan of Merger, dated as of September 3, 2018, by and among Ocean Rig, Transocean Ltd. (RIG), Transocean Oceanus Holdings Limited, and Transocean Oceanus Limited. Ocean Rig shareholders of record at the close of business on October 16, 2018 will be entitled to notice of, and to vote at, the Special Meeting, which is scheduled to be held on Thursday, November 29, 2018, at 9:00 a.m. local time.
|
TRVN | Hot Stocks08:40 EDT Trevena sinks 46% to $1.62 after FDA posts briefing docs ahead of panel
|
AIPT | Hot Stocks08:38 EDT Precision Therapeutics signs distribution agreement with Prenit World - Precision Therapeutics announced that its skyline medical division has partnered with Prenit World, an international distributor of medical infrastructure solutions for healthcare facilities, to market the Streamway System in India. Signing this international distribution agreement represents the company's entry into India's bourgeoning healthcare market. Prenit World has provided technologically advanced and superior quality medical infrastructure solutions to operating theaters and other healthcare facilities in India. Under the terms of the agreement, Prenit World will be the exclusive distributor of the Streamway System, as well as its associated filters and cleaning solutions, to hospitals and other healthcare facilities in India.
|
ALCO | Hot Stocks08:37 EDT Alico announces final results of tender offer - Alico, Inc. announced the final results of its previously announced issuer tender offer, to purchase up to $19,999,990 in value of shares of its common stock at a purchase price of $34.00 per share. The Tender Offer expired at the end of the day, 12:00 midnight, Eastern Daylight Time, on October 3, 2018. Based on the final count by Computershare, the depositary for the Tender Offer, a total of 4,775,863 shares were properly tendered and not withdrawn. In accordance with the terms and conditions of the Tender Offer and based on the final count by the depositary, the Company has accepted for purchase 752,234 shares of its common stock at a purchase price of $34.00 per share, for an aggregate cost of $25,575,956, excluding fees and expenses relating to the Tender Offer. These shares represent approximately 9.2% of the total number of shares of the company's common stock issued and outstanding as of October 2, 2018. Included in the 752,234 shares the company accepted for purchase in the Tender Offer are 163,999 shares that the company has elected to purchase pursuant to its right to purchase up to an additional 2% of its outstanding shares of common stock. Alico's largest shareholder, 734 Investors, LLC, which is an affiliate of George Brokaw and Remy W. Trafelet, Alico's Executive Vice Chairman and CEO, respectively, has participated in the Tender Offer.
|
RTTR | Hot Stocks08:35 EDT Ritter Pharmaceuticals presents additional data from Phase 2b trial of RP-G28 - Ritter Pharmaceuticals presented additional data from its previously completed Phase 2b trial of RP-G28 exhibiting colonic microbiome adaptation and improved lactose tolerance. Data showed significant increases in several species of bacteria that are associated with lactose metabolism in the active treatment groups, compared to placebo. Notably, bifidobacteria increased in 77.7% of patients in the RP-G28 groups. Further, the poster identified that RP-G28 treatment resulted in improved lactose tolerance and increased milk consumption two times 30 days following treatment, compared to placebo.
|
REFR | Hot Stocks08:34 EDT Research Frontiers announces agreement with material science company Gauzy - Research Frontier and Israel-based material science company Gauzy Ltd. announced that Gauzy will be producing SPD-Smart light control film for the entire SPD-SmartGlass industry. The company notes, "SPD-Smart light control film, invented and patented by Research Frontiers, is a key component in SPD-SmartGlass products. This film allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Products using Research Frontiers' smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings."
|
ITI | Hot Stocks08:33 EDT Iteris awarded $1.8M SaaS contract by South Carolina DOT - Iteris announced that the South Carolina Department of Transportation, or SCDOT, has awarded a $1.8 million contract to use Iteris iPeMS to support its statewide transportation network's performance management program for five years, representing the continued adoption of its software-as-a-service, or SaaS, solutions.
|
D | Hot Stocks08:32 EDT Dominion CFO Mark McGettrick to retire, James Chapman to succeed - Dominion Energy announced that Mark McGettrick, executive vice president and CFO, will retire on Jan. 1, 2019, capping a 38-year career at the company. Effective Nov. 1, 2018, McGettrick will step down as CFO. James Chapman, senior vice president-Mergers & Acquisitions and treasurer, will succeed McGettrick as CFO. McGettrick will assist Chapman during the two-month transition. Chapman came to Dominion Energy in 2013 after more than 20 years in investment banking and corporate finance, principally related to the utility and energy sector. Among his roles, he was managing director and head of Asia Pacific Power & Utilities Investment Banking at Barclays plc, as well as holding similar senior roles at Barclays and its predecessor firm, Lehman Brothers in New York and overseas.
|
EVRI CZR | Hot Stocks08:27 EDT Everi Holdings announces CentralCredit services agreement with Caesars - Everi Holdings (EVRI) announced that it has entered into a three-year agreement with Caesars (CZR) to provide its CentralCredit services to select Caesars casino properties. This service is used by casino operators to make real-time decisions when it comes to extending credit lines for guests. Everi's CentralCredit service is the industry's largest gaming credit bureau and the leading source of casino-related credit information and reporting. Used to determine guest credit worthiness, the service enables casino operators to access credit reports and updates on guest activity through a private, secure interface. The service features real-time updates to casino activity and international gaming credit data.
|
SGMS | Hot Stocks08:27 EDT Scientific Games to acquire Don Best Sports and DBS Canada - Scientific Games announced that it has entered into an agreement to acquire Don Best Sports Corporation and DBS Canada. The deal will expand Scientific Games' B2B sports betting offerings and add powerful new capabilities to the company's one-stop shop for sportsbook solutions. Subject to customary conditions to closing, the deal is estimated to close in the Q4.
|
VZ | Hot Stocks08:24 EDT Verizon announces strategic agreement with Mutualink - Verizon has teamed with Mutualink to provide interoperable critical communications solutions that will allow first responders and related entities to securely connect their organization's networks to communicate and share real time video and critical information. Mutualink is a service compatible with virtually any device and network, based on a software centric model that removes hardware dependencies, allowing connections between smartphones, video cameras, land mobile radios, etc.
|
INFN | Hot Stocks08:21 EDT Infinera appoints David Heard as COO - Infinera announced the appointment of David Heard as COO, effective October 1. Heard is responsible for leading the integration of Coriant, the innovation of new solutions and the overall operation of the company. Heard joined Infinera in June 2017 to lead the company's product and solutions team and served as senior VP and general manager. Prior to joining Infinera, Heard served in numerous executive leadership roles.
|
XELA | Hot Stocks08:19 EDT Exela Technologies secures $100M contract from a global bank - Exela Technologies announced that it was selected to provide payment and exception processing services for a global bank and financial services company. The new business is an expansion of the existing relationship spanning more than a decade and covers new services to further the bank's digital journey. The new business is anticipated to be fully ramped in Q1 of 2019. Exela's banking solutions enable banks and financial institutions to deploy Exela's proprietary technologies across many functions on a standalone or integrated basis. By leveraging its global footprint and proprietary technology to deliver location agnostic deployments, Exela's mission is to enable customers on their digital journey. Exela combines digital platforms and knowledge workers to drive efficiency and quality throughout its customers' business processes, providing aid in data aggregation, processing, decisioning, and communications.
|
AVYA | Hot Stocks08:17 EDT Avaya invests in Cogito, accelerates joint development work - Avaya Holdings announced its investment in Cogito, a leader in AI for emotional intelligence that enables organizations to sense human behavior and guide call center agents to enhance productivity and customer experience. Cogito is a founding member of Avaya's A.I.Connect developer ecosystem. The two companies also announced the acceleration of their joint development work to integrate Cogito's AI with Avaya's industry-leading Contact Center solutions. Avaya's A.I.Connect initiative focuses on bringing together an ecosystem of vendors and developers who take an active role in building AI driven solutions. These solutions enable Avaya customers to deliver more engaging experiences for their own end customers, enhancing and integrating workflows with smarter, more personalized interactions through the use of technology. Cogito enhances the emotional intelligence of customer-facing professionals by applying behavioral science through AI Cogito's software evaluates hundreds of behavioral signals through voice to provide live conversation coaching for agents and a real-time measure of customer experience for every call. Avaya's investment is part of Cogito's Series C round of financing. Cogito will use this funding to accelerate go-to-market, expand research and development, and grow its team.
|
CACI | Hot Stocks08:16 EDT CACI awarded $162M task order from U.S. Army PM MC - CACI International announced that it has been awarded a task order, with a ceiling value of $162M, to provide engineering, logistics, and business management support to the U.S. Army's Project Manager Mission Command, or PM MC. The five-year task order, awarded under the General Services Administration OASIS contract, represents new work for CACI in its Communications market area.
|
DGLY AMZN | Hot Stocks08:16 EDT Digital Ally joins Amazon Web Services partner network - Digital Ally (DGLY) announced that it is now a member of the Amazon (AMZN) Web Services, or AWS, partner network, or APN. Through this collaboration, Digital Ally will work hand in hand with AWS, receiving business, technical, marketing, and go-to-market support from AWS that will benefit Digital Ally's customers and help them take full advantage of the benefits of the AWS Cloud. Digital Ally will continue to grow its law enforcement and commercial customer base.
|
APEN | Hot Stocks08:15 EDT Apollo Endosurgery, Slater Endoscopy announce distribution agreement - Apollo Endosurgery announced that it has entered into an agreement with Slater Endoscopy to distribute the cold Ensizor Flexible Endoscopic Scissors in the United States, Europe, and select other markets. The Ensizor Flexible Endoscopic Scissor is indicated to cut and dissect tissue and sutures during endoscopic procedures. The innovative Edge Flex technology greatly enhances the cutting performance of endoscopic scissors by offering a very thin, yet rigid blade construction. The rigid armature provides unparalleled strength while the flexible blades ensure constant cutting contact providing physicians reliable and consistent cutting performance. The Ensizor Flexible Endoscopic Scissors are available for sale immediately through Apollo in the United States and select European countries.
|
AES | Hot Stocks08:14 EDT AES Corp. appoints Sanjeev Addala as Chief Information Digital Officer - AES Corporation (AES) announced the appointment of Sanjeev Addala to the newly created position of Chief Information Digital Officer. Addala joins AES from GE Renewable Energy (GE), where he served as Chief Digital Officer since 2016.
|
JWA JWB | Hot Stocks08:13 EDT John Wiley & Sons agrees to acquire Learning House from Weld North - John Wiley & Sons announced it has signed a definitive agreement to acquire Learning House from Weld North Holdings. Under the terms of the agreement, Learning House shareholders will receive $200M in cash. The transaction is expected to close on or around November 1, 2018, subject to customary closing and regulatory conditions. Learning House, headquartered in Louisville, provides online program management services for colleges and universities, including graduate and undergraduate programs; short courses, bootcamps, and other skills training and credentialing for students and professionals; pathway services for international students; professional development services for teachers; and learning solutions for corporate clients. Revenue for fiscal year 2018 is forecast to be approximately $70M, up 17% from the prior year. Learning House and Wiley's existing Education Services business will combine to create a diversified software and services leader in the $2.3B OPM market, with approximately $200M in combined annual revenue, over 60 university partners ranging from national to regional, over 800 online graduate and undergraduate degree programs across disciplines, and targeted institutional services such as student recruitment and enrollment. Learning House will further extend Wiley's reach into the $10B+ education services space, with short courses, bootcamps, and training services in critical areas like software development and teaching, and a job matching network of more than 450 employers.
|
WSTG | Hot Stocks08:12 EDT Wayside Technology appoints Steve DeWindt as CEO - Wayside Technology announced that the board has appointed Steve DeWindt, as the company's president and CEO effective October 5. DeWindt has been serving as the company's interim president and CEO since May 11. He will continue to serve as a member of the company's board. DeWindt is a technology industry veteran with deep experience in distribution and software solutions.
|
INXN | Hot Stocks08:10 EDT Interxion appoints John Doherty as CFO - Interxion (INXN) announced that it has named John Doherty as CFO, effective November 1. Doherty brings over 25 years of experience in key leadership roles at Verizon (VZ), most recently as Senior Vice President of Corporate Development and Chairman and Chief Investment Officer of Verizon Ventures.
|
PEB LHO | Hot Stocks08:10 EDT Pebblebrook, LaSalle provide update on pending merger transaction - Pebblebrook Hotel Trust (PEB) and LaSalle Hotel Properties (LHO) announced today that their pending merger transaction is on schedule for a planned closing date of November 30, 2018. Pebblebrook and LaSalle will each hold a special meeting of its shareholders on November 27, 2018 to approve Pebblebrook's proposed acquisition of LaSalle. Pebblebrook and LaSalle shareholders of record as of the close of business on October 23, 2018 will be entitled to vote at the applicable special meeting of shareholders. Additionally, the companies announced that the joint proxy statement/prospectus, which was filed as part of a registration statement on Form S-4 in connection with the proposed merger, is expected to be declared effective by the U.S. Securities and Exchange Commission on October 29, 2018. As previously announced on September 6, 2018, Pebblebrook and LaSalle entered into a definitive merger agreement pursuant to which Pebblebrook will acquire 100% of LaSalle's outstanding common shares. Under the terms of the merger agreement, for each LaSalle common share owned, each LaSalle shareholder may elect to receive either a fixed amount of $37.80 in cash or a fixed exchange ratio of 0.92 Pebblebrook common share. A maximum of 30% of the outstanding LaSalle common shares may elect to receive cash. The transaction is subject to customary closing conditions, including approval by LaSalle shareholders and Pebblebrook shareholders.
|
ICAD | Hot Stocks08:09 EDT iCAD's Xoft system selected by SUNY Upstate Medical University - iCAD, Inc. announced that its Xoft Axxent Electronic Brachytherapy System is now available at Upstate Medical University. Affiliated with the State University of New York, Upstate Cancer Center is the first facility in central New York State to offer treatment of early-stage breast cancer using intraoperative radiation therapy with the advanced Xoft System. The hospital is the only academic medical center in the area and serves 1.8 million people.
|
KIM | Hot Stocks08:07 EDT Kimco Realty announces Q3 sales volume $156.8M - Kimco Realty announced transaction activity for the third quarter and year to date 2018. During the third quarter of 2018, the company sold 10 shopping centers and two land parcels totaling 1.3M square feet for $156.8M. Kimco's share of the sales price was $153.7M. The dispositions included Skyline Village, a 190,000-square-foot property in Harrisonburg, Virginia for $32.5M, Temple Towne Center, a 264,000-square-foot property in Temple, Texas for $26.9M, and Kirkwood Crossing, a 253,000-square-foot property in Kirkwood, Missouri for $15.9M. For the nine months ended September 30, 2018, the company's dispositions have included 48 shopping centers and 6 land parcels, totaling 6.3M square feet, for a gross sales price of $712.9M. Kimco's share of the sales price was $685.5M. The blended cap rate for the property sales is in line with the company's expected range of 7.50% to 8.00%.
|
AGRX | Hot Stocks08:07 EDT Agile Therapeutics completes formal dispute resolution process with FDA - Agile Therapeutics announced that it has received a response from FDA's Office of New Drugs, or OND, concerning the company's formal dispute resolution request. The company had appealed the decision by the FDA's Division of Bone, Reproductive and Urological Products, or DBRUP, that concerns surrounding the in vivo adhesion properties of Twirla prevent its approval. While OND has formally denied the company's appeal, OND provided a path forward without the need to reformulate Twirla or conduct a bioequivalence study between formulations, as previously suggested by DBRUP. OND suggested that the company conduct a wear study to evaluate whether Twirla demonstrates a generally similar adhesion performance to Xulane, the generic version of the previously marketed Ortho Evra contraceptive patch, a product the FDA considers to have acceptable adhesion. If this result is demonstrated, OND stated that the study would support the conclusion of adequate Twirla adhesion. OND has recommended that the company first meet with DBRUP to gain agreement on the specific design and success criteria of a wear study for Twirla. Generally, wear studies are conducted by generic companies during the Phase 1 development of transdermal products and are significantly smaller in scope and shorter in duration than typical Phase 3 contraceptive clinical trials. The wear study suggested by OND provides a path forward but does not address efficacy. Rather, if the wear study is successful, Twirla's safety and efficacy, including the Pearl Index, will need to be reviewed by FDA after the company resubmits the NDA for Twirla. This is an issue that DBRUP plans to bring to advisory committee after the adhesion issue has been resolved.
|
IPAS | Hot Stocks08:05 EDT iPass announces grant of new U.S. patent for Wi-Fi roaming experience - iPass Inc announced it has been granted United States Patent no. 10,080,209, issued on September 18th 2018, covering a means to identify whether a Wi-Fi access point is moving or stationary. Called Hop on/Hop off, the innovation analyzes telemetry data from a moving device that is connected to a Wi-Fi access point to determine whether the access point is also moving. The improved classification of Wi-Fi access points means that iPass SmartConnect users will always be connected to the best available network, even when their devices are moving. Hop on/Hop off enhances the experience for users in two key scenarios. For example, if a moving user is listening to a music streaming service while driving down a city street, their device won't connect to irrelevant networks, thereby limiting service disruption and preserving battery life. Likewise, a user on a Wi-Fi enabled airplane, train or bus can automatically connect to the iPass network where available.
|
ONCS | Hot Stocks08:04 EDT OncoSec closed first $8M tranche of investment from Alpha Holdings - OncoSec Medical Incorporated announced the closing of the first $8M tranche of its $15M investment from Alpha Holdings. This value-focused, fundamental strategic investment is centered on the clinical development of OncoSec's lead immunotherapy product candidate, TAVO. TAVO enables the intratumoral delivery of DNA-based interleukin-12, a naturally occurring protein with powerful immune-stimulating functions. Alpha Holdings is a leading Korean technology company engaged in the design, development, service and manufacture of system semiconductors, as well as the development of biotechnologies and thermal compound materials. Under the terms of the agreement, Alpha Holdings has committed to purchase a total of $15M worth of shares of common stock from OncoSec in two tranches at $1.50 per share. The two tranches are each subject to a six-month holding requirement from date of funding. The closing of the second tranche is subject to the satisfaction of certain closing conditions.
|
GTIM | Hot Stocks08:04 EDT Good Times Restaurants reports Q4 SSS up 0.5% for Good Times' brand - Good Times Restaurants announced that its Bad Daddy's adjusted same store sales increased 0.7% during the quarter over the prior year's increase of 1.4%, excluding the impact of Hurricane Florence during which the concept experienced closures for seven store days, including five store days among the base of comparable stores as well as reduced traffic in its North Carolina restaurants in the days immediately preceding and succeeding landfall. Bad Daddy's same store sales decreased 0.7% for the quarter including the lost sales due to the hurricane. Same store sales for its Good Times' brand increased 0.5% in its fiscal fourth quarter ended September 25, 2018 over the prior year's increase of 3.9%.
|
AHT | Hot Stocks08:02 EDT Ashford Hospitality to acquire La Posada de Santa Fe in New Mexico for $50M - Ashford Hospitality Trust announced that it has entered into a definitive agreement to acquire the 157-room La Posada de Santa Fe in Santa Fe, New Mexico for $50M. The acquisition is expected to close in late October, but because the transaction is subject to customary closing conditions, the Company can give no assurance that the purchase will be consummated by such date, or at all. Inclusive of the funds provided by Ashford under the ERFP, and assuming the Ashford funding were to occur at closing, the adjusted net purchase price equates to approximately $287,000 per key and represents, as of August 31 a trailing 12-month capitalization rate of 5.3% on hotel net operating income of $2.4M and a trailing 12-month 15.2x Hotel EBITDA multiple, according to the Company's preliminary estimates based on unaudited operating financial data provided by the sellers.
|
GCAP | Hot Stocks07:58 EDT Gain Capital commences $50M modified Dutch auction tender offer - GAIN Capital Holdings announced that it commenced a "modified Dutch auction" tender offer to purchase up to $50M of shares of its common stock, or such lesser number of shares of its common stock as are properly tendered and not properly withdrawn, at a price not less than $7.24 nor greater than $7.94 per share of common stock, to the seller in cash, less any applicable withholding taxes and without interest.
|
SHLD | Hot Stocks07:50 EDT Sears names Alan Carr to board of directors - Sears announced that Alan Carr, Managing Member and CEO of Drivetrain, has joined the Board of Directors. Carr has significant experience as a principal, investor and advisor leading complex financial restructurings, as well as serving as a director of reorganized businesses in the U.S. and Europe. Carr was previously an attorney at Skadden, Arps, Slate, Meagher & Flom LLP and Ravin, Sarasohn, Baumgarten, Fisch & Rosen.
|
ZIOP | Hot Stocks07:48 EDT Ziopharm's restructuring 'delays inevitable bankruptcy,' Feuerstein tweets - STATNews' Adam Feuerstein tweeted: "$ZIOP won't have a response submitted for FDA clinical hold on its CD-19 CAR-T program until 2H '19. Why bother? Today's restructuring delays inevitable bankruptcy." Reference Link
|
ZIOP | Hot Stocks07:45 EDT Ziopharm affirms guidance on planned Phase 1 trial to evaluate SB-modified TCRs
|
ZIOP | Hot Stocks07:45 EDT Ziopharm expects to respond to FDA's request for information in 2H19 - Ziopharm updated guidance on the timing of its response to the request for more information from the U.S. Food and Drug Administration regarding the clinical hold placed on the investigational new drug application for its third-generation Phase 1 trial to evaluate CD19-specific CAR-T therapies under P-O-C technology. Ziopharm expects to respond to the FDA's request for information in the second half of 2019. Ziopharm also affirmed its guidance on the planned Phase 1 trial to evaluate SB-modified TCRs to treat solid tumors. As disclosed in Ziopharm's second quarter business update, the IND application for this Phase 1 trial, which is being led by and conducted at the National Cancer Institute, remains on track to be submitted in the fourth quarter of 2018 followed by enrollment of patients beginning in 2019, pending regulatory clearance.
|
WVE | Hot Stocks07:34 EDT Wave Life Sciences plans to develop programs in rare, genetic eye diseases - Wave Life Sciences announced plans to design and advance stereopure oligonucleotide therapeutics for the potential treatment of rare, inherited eye diseases. Wave's research in ophthalmology will initially focus on the following four inherited retinal diseases which commonly lead to progressive vision loss typically starting in childhood or adolescence: retinitis pigmentosa due to a P23H mutation in the RHO gene, Stargardt disease, Usher syndrome type 2A and Leber congenital amaurosis 10. The company expects to announce its first ophthalmology development candidate in the second half of 2019. Wave's decision to expand its therapeutic pipeline into ophthalmology is supported by its data presented at the 14th Annual Meeting of the Oligonucleotide Therapeutics Society. The data demonstrate that a single intravitreal injection of stereopure oligonucleotide in the eye of non-human primates resulted in greater than 95% knockdown of a target RNA in the retina for at least four months. Based on these data, the company is working to design development candidates that could achieve a therapeutic effect with only two doses per year. Wave's research will assess four genetic targets, RHO P23H, USH2A, ABCA4 and CEP290 to address four rare, inherited retinal diseases. The company estimates that approximately 10,000 U.S. patients could potentially be treated by Wave's approach to addressing these four diseases.
|
ARAY | Hot Stocks07:34 EDT Accuray announces Technischen Universitat Munchen used Radixact in patient - Accuray announced that the Klinikum rechts der Isar der Technischen Universitat Munchen, or TUM, clinical team has treated the first cancer patients in Germany with the innovative Radixact System. This next-generation helical radiation therapy technology replaced an existing, earlier generation TomoTherapy System at TUM, reinforcing its value to the hospital as a workhorse radiation therapy device capable of treating a wide range of indications from simple to complex. The TUM patients were treated for breast cancer, head and neck tumors, prostate cancer and spinal tumors.
|
AAXN | Hot Stocks07:32 EDT Axon announces first agencies to equip officers with Taser 7 weapon - Axon announced Fort Worth Police Department, or FWPD, a Major Cities Chiefs Association member, and Nevada Highway Patrol, a state and provincial agency, as the first agencies to equip officers with Axon's new TASER 7 weapon. FWPD placed orders for 1,193 TASER 7 devices and NHP placed orders for 889 TASER 7 devices. These orders were received in the Q3 and will ship in the Q4.
|
QCOM... | Hot Stocks07:32 EDT Qualcomm names Martin Anstice, Irene Rosenfeld to board of directors - Qualcomm (QCOM) announced the appointment of Martin Anstice, CEO of Lam Research (LRCX), and Irene Rosenfeld, former Chairman and CEO of Mondelez International (MDLZ), to its Board of Directors. Both Anstice and Rosenfeld bring significant business knowledge and operational experience that will be valuable to Qualcomm as it works to execute against its strategic plan to drive continued growth and excellence in mobile and diversify into industries that are being redefined and transformed by the transition to 5G. These industries include Automotive, Internet of Things, Mobile Compute and Networking.
|
KL | Hot Stocks07:28 EDT Kirkland Lake Gold announces Q3 gold production of 180,155 ounces - Kirkland Lake Gold announced record quarterly gold production of 180,155 ounces for Q3. Production in Q3 exceeded target levels for the quarter driven by record quarterly production from Fosterville of 90,618 ounces as well as from the company's Canadian operations, with Macassa, Holt and Taylor collectively producing 89,537 ounces. The company completed Q3 well positioned to achieve the improved FY18 consolidated production guidance of over 635,000 ounces. Gold poured in Q3 totaled 187,331 ounces, with total gold sales of 184,509 ounces. Tony Makuch, president and CEO of Kirkland Lake Gold, commented, "Q3 2018 was a record quarter for both Fosterville in Australia and our Canadian operations as a whole. At Fosterville, we commissioned a second gravity circuit during Q3 2018 and saw an immediate spike in production, with the Fosterville Mill processing over 18,000 ounces in the first week of the circuit's operation. This spike can largely be attributed to the gravity circuit's effectiveness in recovering gold previously contained in the recirculating load of the grinding circuit. We also mined and processed our first Swan Zone stope during the quarter, which contributed over 7,500 ounces of production at an average grade of close to 40 g/t, in line with target levels. Turning to our Canadian operations, record production across our three mines reflected strong results at Macassa, where Q3 2018 production was very much in line with target levels, our best quarter of production to date at Holt and a better production performance from Taylor Mine compared to the previous quarter. Heading into the final quarter of the year, we are very well positioned to achieve our improved 2018 consolidated production guidance of over 635,000 ounces."
|
IPIX | Hot Stocks07:21 EDT Innovation Pharmaceuticals secures up to $10M in additional financing - Innovation Pharmaceuticals reports that it has secured new financing for up to $10M from one multi-family office focused on healthcare and life sciences, including an initial net placement of approximately $2.2M over the first 30 days. These funds will be used to continue to advance the company's pipeline of first-in-class drug candidates: Brilacidin for Oral Mucositis, Kevetrin for Ovarian Cancer and Prurisol for Psoriasis. The company entered into a Securities Purchase Agreement pursuant to which the company agreed to sell preferred stock that is convertible to its Class A common stock and warrants in a registered direct offering, without an underwriter or placement agent. The first tranche of the Offering is anticipated to close on October 9, 2018. "This new financing serves to further bolster our balance sheet and gives us flexibility in working to meet our near-term goals, which includes advancing Brilacidin into a pivotal study," said CEO Leo Ehrlich. "The company is at an exciting juncture, with our three novel drug candidates successfully reaching mid- and later-stage trials across multiple indications representing large market opportunities. We remain steadfast in delivering innovative medicines to patients and increasing the company's valuation."
|
MGTX | Hot Stocks07:16 EDT MeiraGTx acquires Vector Neurosciences, AAV-GAD gene therapy product candidate - MeiraGTx announced that it has acquired Vector Neurosciences in an all-stock transaction. As a result of the acquisition, which was signed and closed, MeiraGTx has expanded its portfolio of clinical stage product candidates to include adeno-associated virus encoding glutamic acid decarboxylase, or AAV-GAD, a gene therapy product candidate ready for continued Phase 2 clinical development for Parkinson's disease. A prior Phase 2 clinical trial of AAV-GAD was completed and was the first successful randomized, double-blind, sham-controlled trial of its kind for a gene therapy product candidate targeting a brain disorder.
|
ZIOP XON | Hot Stocks07:14 EDT Ziopharm, Intrexon subsidiary announce new definitive license agreement - Ziopharm (ZIOP) and Precigen, a wholly-owned subsidiary of Intrexon (XON), announced a new definitive license agreement to replace all existing agreements between the companies that will provide Ziopharm with certain exclusive and non-exclusive rights to technology controlled by Precigen. Through the new agreement, Ziopharm will primarily focus its resources on developing its Controlled IL-12 and Sleeping Beauty, or SB, T-cell receptor, or TCR platform technologies which have the capability to treat solid tumors, while Intrexon further establishes Precigen as a therapeutics company concentrating on immuno-oncology, autoimmune and infectious disease therapies. Both companies will be better positioned to independently focus on their respective platforms and markets with full developmental and financial controls. With this exclusive license, Ziopharm now has full developmental control and exclusivity utilizing SB for TCRs targeted towards neoantigens and public antigens. The existing cooperative research and development agreement, or CRADA, with the National Cancer Institute related to SB-generated T cells expressing TCRs to target neoantigens buried within solid tumors will be transferred to Ziopharm, and Ziopharm will maintain this exclusive relationship with the NCI for this program. Ziopharm will build on its IL-12 platform utilizing Precigen's RheoSwitch gene switch with both the existing human adenovirus program and now with rights to pursue next-generation viral technologies. Using the SB system, Ziopharm will continue to advance its CD19-specific chimeric antigen receptor, or CAR, program, while retaining rights to a second, unnamed CAR target. Precigen gains exclusive rights for all other CAR-T therapies, including CD33-specific CAR-T therapies.
|
VSTM | Hot Stocks07:12 EDT NCCN adds Verastem's COPIKTRA to clinical practice guidelines for CLL/SLL - Verastem announced that the National Comprehensive Cancer Network added COPIKTRA capsules to the Clinical Practice Guidelines in Oncology for chronic lymphocytic leukemia/small lymphocytic lymphoma. COPIKTRA is an oral inhibitor of phosphoinositide 3-kinase, and the first approved dual inhibitor of PI3K-delta and PI3K-gamma. The U.S. Food and Drug Administration granted approval to COPIKTRA on September 24, 2018, for the treatment of adult patients with relapsed or refractory CLL/SLL after at least two prior therapies. Based on efficacy and safety data from patients with at least two prior lines of therapy who were treated in the randomized, Phase 3 DUO trial, the NCCN Guidelines now include a Category 2A recommendation for use of COPIKTRA for adult patients whose disease is relapsed or refractory after treatment with at least two prior therapies. The Category 2A recommendation indicates that based upon lower-level evidence, there is uniform NCCN consensus that COPIKTRA is appropriate for these patients.
|
GTHX | Hot Stocks07:08 EDT G1 Therapeutics announces new data from Phase 2 trilaciclib trial at ESMO - G1 Therapeutics announced that new data from its randomized Phase 2 clinical trial of trilaciclib in combination with etoposide/carboplatin for treatment of first-line small cell lung cancer, or SCLC, will be presented at the European Society for Medical Oncology, or ESMO. The company reported topline data from this trial in March showing myelopreservation benefits. Additional data from this trial have been selected for a poster discussion session on October 21. A second poster with new data focused specifically on the impact of trilaciclib on immune system function, including preservation of T cell subsets such as activated CD8+ T cells and an increased CD8+/regulatory T cell ratio in peripheral blood compared to placebo, will be presented on October 20.
|
MYGN PFE | Hot Stocks07:06 EDT Myriad, Pfizer build upon previously announced companion diagnostic agreement - Myriad Genetics (MYGN) announced that it has signed a commercialization plan with Pfizer (PFE). The plan is under an existing companion diagnostic agreement, in which Myriad is pursuing U.S. Food and Drug Administration approval for its BRACAnalysis CDx to be used as a companion diagnostic with Pfizer's investigational PARP inhibitor, talazoparib. Talazoparib and BRACAnalysis CDx currently are under FDA review, with New Drug Application and Supplementary Premarket Approval submissions based on results from the EMBRACA trial, which evaluated talazoparib versus physician's choice chemotherapy in patients with germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer. Myriad anticipates a regulatory decision from the FDA by December 2018.Under the commercialization plan, each company remains responsible for the commercialization of its respective product. However, the companies will collaborate on certain commercial activities intended to support the use of the BRACAnalysis CDx in identifying patients for potential treatment with talazoparib following FDA approval. "We believe this commercial collaboration is another strong indication of Myriad's global leadership in the field of companion diagnostics for PARP inhibitors and personalized medicine," said Lloyd Sanders, president of Myriad Oncology. "We are excited to be working with Pfizer and towards ensuring patients have access to this class of drugs."
|
HLNE | Hot Stocks07:06 EDT Hamilton Lane partners with Cristo Rey Philadelphia - Hamilton Lane has once again partnered with Cristo Rey Philadelphia for the 2018-2019 school year. Cristo Rey is an independent, Catholic college preparatory school for students of all faiths who could not otherwise access a private education. As a job partner, Hamilton Lane will host student-interns at its Bala Cynwyd headquarters as part of the Cristo Rey curriculum that combines rigorous academics with professional on-site work experience in the form of a work-study program. One of the primary goals of the work-study program is to help students develop lifelong skills and create professional networks that they can carry with them to and beyond college. As part of the partnership, Hamilton Lane has made a financial commitment to the school that funds 65% of each student intern's tuition.
|
ACBFF | Hot Stocks07:04 EDT Aurora Cannabis announces application to list on NYSE - Aurora Cannabis announced that the company has filed an application to list its common shares on the New York Stock Exchange. Listing of the company's common shares on the NYSE remains subject to the approval of the NYSE and the satisfaction of all applicable listing and regulatory requirements. Aurora anticipates that, subject to receipt of all required approvals, trading in its common shares on the NYSE will commence before the end of October 2018. In advance of the intended listing, the company has filed a Form 40-F Registration Statement with the United States SEC. Aurora's shares will trade on the NYSE under ticker symbol "ACB", the same symbol the company's common shares currently, and will continue to, trade under on the Toronto Stock Exchange. Aurora will also continue to trade on the OTCQX under the ticker symbol "ACBFF" until completion of the NYSE listing. Upon receipt of all required approvals and completion of the formal listing process, the company will publicly announce its first trading date on the NYSE. Aurora furthermore intends to voluntarily delist its shares from the OTCQX at such time.
|
COG | Hot Stocks07:04 EDT Cabot Oil & Gas announces new takeaway capacity on Leidy South expansion - Cabot entered into a precedent agreement with Transco for 250,000 MMBtu per day of firm transportation capacity on the Leidy South expansion project. Cabot's capacity will deliver natural gas from the Zick interconnect in Susquehanna County, Pennsylvania to the River Road interconnect in Transco's Zone 6. The company will also be participating as an equity owner through its ownership in the Meade Pipeline. The project is anticipated to be in-service as early as Q4 of 2021 assuming all necessary regulatory approvals are received in a timely manner.
|
STAA | Hot Stocks07:04 EDT STAAR Surgical, Dr. Tobias Neuhann announces strategic alliance agreement - STAAR Surgical Company announced a multi-year Strategic Alliance Agreement with Dr. Tobias Neuhann of the Augenklinik am Marienplatz in Munich, Germany. The agreement serves as a global partnership model for smaller and single site refractive surgery eye clinics that aim to provide STAAR's EVO Visian ICL intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses.
|
CHEK | Hot Stocks07:02 EDT Check-Cap submits IDE to FDA to advance studies of C-Scan - Check-Cap announced that it has submitted an Investigational Device Exemption, or IDE, to the FDA to advance studies of C-Scan. If approved, the Company plans to initiate a U.S. pilot study during the Q4.
|
MAXR | Hot Stocks07:02 EDT Maxar Technologies advances planned U.S. domestication - Maxar Technologies announced that it is advancing its domestication into the United States and expects to complete this process in January 2019, subject to securityholder approval. Maxar will continue to list its shares on both the New York Stock Exchange and Toronto Stock Exchange. Maxar does not anticipate any impact on its employees, customers, suppliers, or other stakeholders as a result of its U.S. domestication. As previously announced, Maxar will transition to U.S. accounting standards and securities filings effective with its U.S. domestication. The company believes this will make its financial results more transparent to a wider audience of investors and provide increased comparability with U.S. aerospace and defense peer companies. The company committed to U.S. domestication no later than December 31, 2019 as part of its closing of its acquisition of DigitalGlobe on October 5, 2017. The board of directors of Maxar unanimously determined that the U.S. Domestication is in the best interests of Maxar and is fair and reasonable, and unanimously resolved to recommend that Maxar Securityholders vote in favor of the Arrangement.
|
DHI | Hot Stocks07:00 EDT D.R. Horton reports preliminary Q4 home sales revenue up 9% to $4.4B - Reports FY18 homes closed increased 13% to 51,857 homes, compared to 45,751 homes in fiscal 2017. Home sales revenue in FY18 increased 14% to $15.5B from $13.7B in FY17. Net sales orders for the fourth quarter ended September 30, 2018 increased 11% to 11,509 homes from 10,333 homes in the year-ago quarter, and the value of net sales orders increased 10% to $3.4B from $3.1B. The Company's cancellation rate for the Q4 of FY18 was 26%, compared to 25% in same quarter of FY17. Net sales orders for the fiscal year ended September 30, 2018 increased 13% to 52,740 homes from 46,605 homes in FY17, and the value of net sales orders increased 13% to $15.8B from $13.9B. The Company's cancellation rate for FY18 was 22%, unchanged from fiscal 2017. At September 30, 2018, the Company's sales order backlog of homes increased 8% to 13,371 homes and 8% in value to $4.0B, compared to 12,329 homes and $3.7B at September 30, 2017.
|
COG | Hot Stocks06:59 EDT Cabot Oil & Gas reports preliminary Q3 net production 2.03 mmcfe per day - Cabot Oil & Gas provided an operational update on the heels of the in-service of the Atlantic Sunrise project on October 6 and announced the execution of a binding precedent agreement for new pipeline takeaway capacity on Transco's Leidy South expansion project. Due to the delay of the Atlantic Sunrise project's in-service date from the second-half of August to October 6 and a modest change in the timing of the company's Q3 pads being placed-on-production, Cabot preliminarily expects net production for Q3 to be approximately 2,029 million cubic feet equivalent, or mmcfe, per day, representing a 7% sequential increase in daily net production relative to Q2 and a 19% increase relative to the prior-year comparable quarter on a divestiture-adjusted basis. Cabot's current gross operated production volumes are above 2.6B cubic feet per day, representing an increase of over 400M cubic feet per day, or 19%, relative to the company's average daily gross volumes during Q2. Cabot has provided Q4 net production guidance of 2,225-2,275 mmcfe per day. The company has also updated its 2018 daily production growth guidance range from 10%-12% to 7%-8% to reflect the impact of Q3 actuals and the impact of modest changes to the anticipated timing of completions during Q4. As a result of the revised timing of completions, the company has also reduced its full-year capital budget by $20M to $940M.
|
AR | Hot Stocks06:54 EDT Antero Resources announces $600M share repurchase program - Antero Resources board approved a share repurchase program of up to $600 million. The open market share repurchase program is expected to commence during the fourth quarter of 2018 and extend over the next 12 to 18 months, allowing the company to be opportunistic regarding the share repurchase price.
|
AMGP... | Hot Stocks06:52 EDT AMGP to acquire Antero Midstream Partners $30.43 per unit - Antero Midstream GP LP (AMGP) and Antero Midstream Partners LP (AM) announced that they have entered into a definitive agreement for AMGP to acquire all outstanding AM common units, both those held by the public and those held by Antero Resources (AR) , in a stock and cash transaction. In connection with the transaction, AMGP will convert into a corporation and the combined entity will be renamed Antero Midstream Corporation. Under the terms of the agreement, Antero Midstream Partners public unitholders will be entitled to receive a combination of $3.415 in cash and 1.635 shares of New AM stock per AM unit owned, resulting in aggregate consideration valued at $31.41 per AM unit, based on the October 8, 2018 closing price. Antero Resources will be entitled to receive a combination of $3.00 in cash and 1.6023 shares of New AM stock for each AM unit owned, resulting in aggregate consideration valued at $30.43 per AM unit, based on the October 8, 2018 closing price. AM public unitholders will be entitled to elect to receive their merger consideration in all cash, all stock, or a combination of cash and stock, and AR will have the ability to elect to take a larger portion of its merger consideration in cash if the AM public unitholders elect to receive more stock than the mixed election consideration, in each case subject to pro ration to ensure that the aggregate amount of cash consideration paid to all AM unitholders equals approximately $598 million. The transaction has been negotiated and recommended by the Conflicts Committees of AMGP and Antero Midstream Partners and the Special Committee of Antero Resources and approved by all three Boards of Directors. Under the terms of the simplification agreement, AMGP will acquire 100% of Antero Midstream Partners' 188.1 million fully diluted common units outstanding, including 98.9 million common units owned by Antero Resources. AM public unitholders will be entitled to receive a combination of $3.415 in cash and 1.635 shares of New AM stock per AM unit owned, resulting in aggregate consideration valued at $31.41 per AM unit, based on the October 8, 2018 closing price. The all-in consideration for AM public unitholders represents a premium of 7% based on the closing price as of October 8, 2018 and a premium of 19% based on closing prices as of February 23, 2018 prior to the announcement of the Special Committee formation. Antero Resources will be entitled to receive a combination of $3.00 in cash and 1.6023 shares of New AM stock for each AM unit owned, resulting in aggregate consideration valued at $30.43 per AM unit, based on the October 8, 2018 closing price. AM public unitholders will be entitled to elect to receive their merger consideration in all cash, all stock or a combination of cash and stock. AR will have the ability to elect to take a larger portion of its merger consideration in cash if the AM public unitholders elect to receive more stock consideration than outlined in the mixed election, subject to pro ration, to ensure that the aggregate amount of cash consideration paid to all AM unitholders equals approximately $598 million. Following the AM public unitholders' election of their consideration, Antero Resources' can elect additional cash consideration, if available, in lieu of stock consideration. Following the simplification, New AM will eliminate all IDRs in AM and the Series B units, which represent 10-year profits interests in Antero IDR Holdings, the entity that holds all of the outstanding IDRs in AM. The cash consideration will be funded at closing by utilizing borrowings under an amended AM credit facility. AM is in the process of exercising the accordion feature on its credit facility, which would increase capacity from $1.5 billion to $2.0 billion. New AM expects to maintain a strong balance sheet flexing to just over 3.0x net debt to adjusted EBITDA post-closing at the end of the first quarter of 2019 and de-levering into the mid two-times range by 2020. Consistent with AM's previous outlook, New AM does not anticipate a need to access the public equity markets to fund its previously disclosed $2.7 billion in organic growth opportunities from 2018 through 2022.
|
GNK | Hot Stocks06:52 EDT Genco Shipping initiates comprehensive fleet plan ahead of IMO 2020 - Genco Shipping announced that it plans to install exhaust gas cleaning systems on its 17 Capesize vessels with options for installation on an additional 15 minor bulk vessels. The balance of the fleet is expected to consume compliant, low sulphur fuel beginning in 2020, when new environmental regulations come into effect capping sulphur emissions at 0.5%, down from 3.5% currently. Genco will also continue to execute its previously announced fleet renewal program aimed at selling older, less fuel-efficient vessels and redeploying the capital towards high specification, fuel-efficient vessels to further reduce emissions. The company anticipates scrubber installation to be completed in 2019, ahead of the January 1, 2020 deadline. Genco estimates that the cost of each scrubber, including installation, will be approximately $2M. The company is currently in discussions with various lenders in regards to scrubber financing.
|
UAL | Hot Stocks06:51 EDT United Airlines reports September traffic up 6.7% - United Airlines reported September operational results. UAL's September consolidated traffic in revenue passenger miles increased 6.7% and consolidated capacity in available seat miles increased 6.1% versus September 2017. UAL's September consolidated load factor increased 0.5 points compared to September 2017.
|
AMGP AM | Hot Stocks06:49 EDT AMGP to acquire Antero Midstream Partners $30.43 per unit
|
TPR | Hot Stocks06:46 EDT Tapestry signs UN Global Compact - Tapestry announced it has signed onto the UN Global Compact. Tapestry joins over 9,800 companies who are signatories to the UN Global Compact, recognizing its role as a business with the ability to address global issues within the luxury goods sector.
|
CGC... | Hot Stocks06:38 EDT Canopy Growth completes first legal export of cannabis to the U.S. from Canada - Canopy Growth has completed a legal transfer of cannabis products to a research partner in the United States. To the company's knowledge, this transfer is the first export of legal cannabis products from Canada to the United States pursuant to an import permit issued by the federal United States Drug Enforcement Administration, or DEA. The shipment was completed for the sole purpose of supporting medical research and development. Currently, sources of federally regulated cannabis in the United States are limited in scope and genetic diversity. Canopy Growth believes that it can add value to the market and enable the development of testing standards for products, while advancing the understanding of the risks and benefits of medical cannabis. While this export is a major achievement for the company, Canopy Growth strongly supports legal production at the domestic level over ongoing exports.
|
MRK BMY | Hot Stocks06:37 EDT BriaCell initiates dosing in Phase I/IIa combo study with KEYTRUDA or YERVOY - BriaCell Therapeutics is pleased to announce that it has initiated patient dosing in a Phase I/IIa study of its lead clinical candidate, Bria-IMT, in combination with pembrolizumab (KEYTRUDA); manufactured by Merck & Co., (MRK) or ipilimumab (YERVOY); manufactured by Bristol-Myers Squibb Company (BMY). The combination study is listed in ClinicalTrials.gov as NCT03328026.
|
MRK AZN | Hot Stocks06:33 EDT Merck: New data from oncology portfolio, early pipeline to be presented at ESMO - Merck (MRK) announced that new data from Merck's broad oncology portfolio and robust early pipeline will be presented at the European Society for Medical Oncology 2018 Congress in Munich, Germany from October 19-23. More than 100 abstracts involving Merck medicines - including eight late-breaking abstracts - across more than 15 tumor types have been accepted. Additionally, pivotal Phase 3 data evaluating anti-PD-1 therapy KEYTRUDA as a first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma from the KEYNOTE-048 trial and the PARP inhibitor LYNPARZA, in collaboration with AstraZeneca (AZN), as maintenance therapy in newly diagnosed patients with BRCA-mutated advanced ovarian cancer who are in complete or partial response to first-line platinum-based chemotherapy from the SOLO-1 trial are to be presented in the ESMO Presidential Symposium and featured in the official ESMO Press Program.
|
AERI | Hot Stocks06:31 EDT Aerie Pharmaceuticals reports EMA accepted for review MAA for Rhokiinsa - Aerie Pharmaceuticals reported that the EMA has accepted for review the MAA for Rhokiinsa, or netarsudil ophthalmic solution, 0.02%. Rhokiinsa is currently marketed as Rhopressa in the U.S. and is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. An opinion from the EMA's Committee for Medicinal Products for Human Use on the MAA for Rhokiinsa is expected in the second half of 2019.
|
TSM | Hot Stocks06:24 EDT TSMC reports September revenue NT$94.42B, up 7.2% y/y - TSMC announced its net revenues for September 2018: On a consolidated basis, revenues for September 2018 were approximately NT$94.92B, an increase of 4.2% from August 2018 and an increase of 7.2% from September 2017. Revenues for January through September 2018 totaled NT$741.70B, an increase of 6% compared to the same period in 2017.
|
XYF | Hot Stocks06:17 EDT X Financial announces multi-year marketing partnership with NBA China - X Financial and NBA China announced a multi-year marketing partnership that makes the company an official marketing partner of NBA China. X Financial is NBA China's first time cooperating with a company in China's personal finance industry. Starting from the 2018-19 season, NBA China will integrate X Financial and its brands including, Xiaoying Wealth Management and Xiaoying Card Loan, into NBA China's marketing and media platforms to share X Financial's business with NBA China fans. X Financial will also bring NBA players and legends to China to interact with fans and grow the games. As the official marketing partner of NBA China Games 2018, X Financial activated the games with extensive brand inclusion on and off the court. In addition, the company hosted the "X Financial Basketball Club", a fan interactive event in Beijing.
|
WMB | Hot Stocks06:17 EDT Williams executes commitments with Seneca Resources and Cabot Oil & Gas - Williams announced that its Transco interstate pipeline has executed binding, 15-year commitments with Seneca Resources and Cabot Oil & Gas for 100% of the 580M dekatherms of firm transportation capacity under its proposed Leidy South expansion project. The project represents an expansion of vital energy infrastructure that will further connect robust supplies of natural gas in the Marcellus and Utica producing region in Pennsylvania with growing demand centers along the Atlantic Seaboard as early as the Q4 of 2021 assuming all necessary regulatory approvals are received in a timely manner.
|
BAH | Hot Stocks06:16 EDT Booz Allen names Michele Flournoy, Ellen Jewett to board of directors - Booz Allen announced that it has appointed Michele Flournoy and Ellen Jewett to the Board of Directors, effective October 24, 2018 and October 25, 2018, respectively. The company also announced that Philip Odeen, a member of the board for the last decade, will retire from the board effective March 31, 2019.
|
IMOS | Hot Stocks06:13 EDT ChipMOS reports September revenue up 10.5% to $55.7M vs. $50.4M last year - Revenue for the month of September was $55.7M, a decrease of 2.2% from the month of August and an increase of 10.5% from the same period in 2017.
|
E BP | Hot Stocks06:11 EDT Eni, BP, NOC sign deal to resume Libyan exploration - National Oil Corporation Chairman, Mustafa Sanalla, BP (BP) Group CEO Bob Dudley, and Eni (E) CEO Claudio Descalzi, signed a Letter of Intent in London which will launch the process for Eni to acquire a 42.5% stake in BP's Exploration and Production Sharing Agreement in Libya, with an aim to boost in-country exploration and development activities and promote Libya's investment environment. The agreement aims to launch the acquisition process for Eni to obtain a 42.5% participating interest and the assignment of the operatorship, currently held by BP, in the contractual areas A and B and C in Libya. BP holds an 85% working interest of the second party share in each block, with the Libyan Investment Authority holding the remaining 15%. The parties intend to finalize and execute all necessary agreements by current year-end, with the aim of re-starting exploration activities in 2019. This transaction will reinforce and strengthen the existing strategic and privileged partnership between parties over the longer-term.
|
TLRY | Hot Stocks06:02 EDT Tilray acquires Alef Biotechnology - Tilray announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology. The acquisition will allow Tilray to import, produce and distribute Tilray branded medical cannabis products in Chile and to create a hub to distribute Tilray products throughout Latin America. Tilray purchased all the outstanding equity of Alef for approximately C$5M. The purchase was comprised of approximately C$250,000 in cash paid at closing, and C$4,750,000 in Tilray Class 2 common stock, subject to a standard working capital adjustment and Alef achieving certain business milestones within a twelve-month period after closing.
|
HJLI | Hot Stocks06:02 EDT Hancock Jaffe Laboratories enters research pact with Texas Heart Institute - Hancock Jaffe Laboratories announced that it has entered into a Sponsored Research Agreement with Texas Heart Institute for the development of HJLI's CoreoGraft, an off the shelf conduit intended to be used for coronary artery bypass surgery. Founded in 1962 by world renowned cardiovascular surgeon Dr. Denton A. Cooley, the Texas Heart Institute is recognized internationally for research programs in cardiology, cardiovascular surgery, stem cell and gene therapy, and regenerative medicine, and is dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care.
|
WYY | Hot Stocks06:01 EDT WidePoint secures over $18.7M in contract awards - WidePoint announced new contract awards valued at $18.79M. The above-mentioned awards include the following notable details: Multiple agencies exercised contract option years, follow-on contracts and/or issued extensions for a total of $10.5 million in recurring revenue; Several agencies expanded existing contracts for a total of $2.8 million, including the U.S. Coast Guard adding more than $1.1 million to the $12 million base award announced in August 2018; and New task orders and agreements totaling $5.4 million, including a subcontract agreement to provide WidePoint's Intelligent Telecommunications Management System to support the U.S. Department of Defense at the Pentagon. The above contract awards add an additional $20 million in top-line revenues from the period of September 2018 through November 2019.
|
NUVA | Hot Stocks05:29 EDT NuVasive announces strategic partnership with Biedermann Technologies - NuVasive announced it has entered into a strategic partnership with Biedermann Technologies GmbH & Co. KG, a company that holds a broad and extensive patent and technology portfolio in the fields of spinal and extremity surgery, based in Donaueschingen, Germany. Within the terms of the license and services agreement, Biedermann Technologies has granted NuVasive licenses to intellectual property relating to its spinal technology portfolio. Specifically, certain Biedermann Technologies' proprietary screw innovations will be integrated into the NuVasive RELINE portfolio, offering surgeons a superior solution to treat complex spinal pathologies in both the adult and pediatric populations for open, as well as minimally invasive surgery, with customized screw placement and ability to facilitate various corrective maneuvers based on the clinical needs of the patient. NuVasive's RELINE system is the only technology on the market to offer a single tulip that accepts three posterior fixation rods of different diameters and is integrated into its proprietary Integrated Global Alignment, or iGA, platform designed to achieve global alignment across spinal procedures. This combination of Biedermann Technologies' propriety screw technology and NuVasive's RELINE system is expected to be commercially available to surgeons in the first half of 2019. Biedermann Technologies will also provide services to NuVasive in connection with the development of its next-generation RELINE complex spine system to support three foundational clinical pillars: surgical efficiency, operative reliability and procedural versatility.
|
BA AL | Hot Stocks05:19 EDT Boeing, Air Lease deliver first 787 Dreamliner for Air Tahiti Nui - Boeing (BA), Air Lease (AL), and Air Tahiti Nui celebrated the delivery of the airline's first 787-9 Dreamliner, via lease from ALC. This is the first Boeing airplane to join the Tahitian airline, which plans to use the longest-range Dreamliner to replace aging A340s and connect its home base in the South Pacific with world capitals such as Paris, Tokyo and Los Angeles. Air Tahiti Nui joins other carriers in the Pacific who operate long-distance routes in switching to the super-efficient and long-range 787-9. The airplane can fly up to 7,635 nautical miles, while reducing fuel use and emissions by 20 to 25 percent compared to older airplanes.
|